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ABSTRACT 
Ventilator-associated pneumonia (VAP) is a common but preventable health-care 
associated infection that affects up to 20% of mechanically ventilated adult patients, resulting in 
estimated mortality rates ranging from 13% to 55% (Chahoud, Semaan, Almoosa, 2015; Melsen 
et al., 2013). In an effort to reduce morbidity, mortality and related costs, the Centers for 
Disease Control and Prevention (CDC) and the National Healthcare Safety Network (NHSN), 
proposed ventilator-associated pneumonia prevention as a national patient safety goal. In 2014, 
amid growing concerns that the subjectivity of existing definitions had led to inconsistent 
reporting, thereby impeding efforts to reduce VAP, the CDC refocused surveillance efforts on, 
the more broadly defined, ventilator associated events (VAE), which include VAP as well as a 
set of related conditions. Hospitals have been inconsistent in their adoption of evidence-based 
practice (EBP) to reduce the incidence of VAE. The purpose of this EBP project was to design, 
implement, and evaluate the use of a comprehensive oral health intervention to: (a) reduce the 
cumulative VAE rate at four facilities and (b) determine whether project adherence over a four 
month period had an impact on VAE incidence rate reduction.  
The Epidemiological Triangle of Infectious Disease and Everett Rogers’ Diffusion of 
Innovation framework guided this multisite pretest-posttest study. The study introduced oral care 
and biofilm elimination education for nurses, and an oral health assessment tool. Aggregated 
VAE data was collected from each facility’s infection preventionist. The analysis involved pooled 
mean comparisons of data in the pre-intervention and post-intervention periods. The data 
showed a decrease in pooled VAE incidence rates of 1.8 per 1,000 ventilator-days, but this 
difference was not statistically significant, Χ2 (1, N = 4,846) = .37, p = .54. There was also a 
moderate correlation between documentation compliance and reduction of VAE rate (r = .4). 
However, this correlation was not statistically significant (p = .6). These findings provide 
preliminary evidence that routine oral assessment and timely intervention in MV patients are 
useful components of comprehensive oral care practices to prevent VAE. 
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CHAPTER 1 
INTRODUCTION 
Oral care is an important nursing intervention to reduce the risk of ventilator-associated 
pneumonia (VAP) in the hospital setting. While the effectiveness of various oral care practices 
has been studied in several patient populations, the most effective oral care solutions, 
frequency, duration, and strategies for staff education remain unclear. The purpose of this study 
is to answer the PICOT question: Among mechanically ventilated patients, how does the 
implementation of an oral care assessment guideline combined with a mandatory staff 
education program affect the incidence of ventilator associated events (VAE) when compared to 
standard care over a four month period?  This chapter will differentiate VAP from current 
classifications of VAE, provide an overview of how VAP develops in endotracheally intubated 
patients, and describe the significance of this project to prevent VAE in this population. 
Background 
Hospital acquired infections (HAI) encompass almost all clinically evident infections that 
the patient acquires during the course of hospitalization and that do not originate from the 
patient's original admitting diagnosis, according to Mehta et al. (2014) and Paitoonpong, Wong, 
& Perl (2014).  Within hours after admission, a patient's flora begins to acquire characteristics of 
the surrounding environmental flora. Most HAIs become clinically evident after 48 hours of 
hospitalization. Hospital acquired infections may also become evident after the patient's 
discharge from the hospital. These are known as nosocomial in origin (Zimring et al., 2013). 
Ventilator-associated pneumonia is a common HAI and is the leading cause of death 
among hospitalized patients requiring mechanically ventilated airway support (Davis, 2006; 
Klompas, Kleinman, & Murphy, 2014). A recent clinical survey suggests that the prevalence of 
VAP is 9% to 27% among all intubated patients (Dudeck et al., 2011). However, according to 
Choudhuri (2013), it is estimated that the prevalence of ICU-acquired VAP is 10% to 20% and 
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results in crude estimated mortality rates ranging from 24% to 76%. These patients are twice as 
likely to die during hospitalization, compared to mechanically ventilated patients without 
pneumonia, according to the American Thoracic Society (2005). In another study by Klompas et 
al., (2014), researchers concluded that the attributable mortality of VAP is estimated to be 
approximately 10% but varies considerably for different kinds of patient populations. Although 
there have been numerous advances in techniques for the management of mechanically 
ventilated patients, VAP continues to impact morbidity, prolongs intensive care unit (ICU) length 
of stay, and prolongs duration of ventilation. The estimated additional cost to treat VAP exceeds 
$40,000 per occurrence (Davis, 2006; Klompas, Kleinman, & Murphy, 2014). 
Until recently, the definition of VAP has been relatively unstandardized compared to 
other types of HAI. The Centers for Disease Control and Prevention (CDC) indicated that true 
incidence of VAP was difficult to determine due to the subjectivity of VAP surveillance (Klompas, 
Kleinman, & Murphy, 2014; Magill et al., 2013). As a result, from 2011 to 2012, the CDC 
convened a working group comprised of representatives from critical and respiratory care, 
infectious diseases, healthcare epidemiology, and infection prevention professional societies to 
develop a new approach to surveillance for mechanically ventilated patients in an attempt to 
standardize VAP surveillance definitions (Klompas et al., 2014; Magill et al., 2013). The working 
group made two recommendations: 1) to develop new definitions based on objective, 
quantitative criteria to increase the reliability, reproducibility, comparability, and efficiency of 
surveillance, 2) to broaden the scope of surveillance from pneumonia alone to encompass other 
complications of mechanical ventilation. In 2014, the Centers for Disease Control and 
Prevention (CDC) released an updated surveillance definition of VAP, which stratified VAP as 
one of several ventilator-associated events (VAE). These events include ventilator-associated 
conditions (VAC), infection-related ventilator-associated conditions (IVAC), possible VAP, and 
probable VAP. All of these events are of interest to this study, as they represent preventable 
adverse outcomes. 
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Ventilator associated condition (VAC) is defined as a period of sustained respiratory 
deterioration following a sustained period of stability or improvement while mechanically 
ventilated, as evidenced by changes in the daily minimum fraction of inspired oxygen (FiO2) or 
daily minimum positive end-expiratory pressure (CDC, 2014). 
Infection-related ventilator-associated complication (IVAC) is triggered by the presence 
of possible infection indicators concurrent with VAC onset. IVAC is said to have occurred in the 
presence of abnormal temperature, below 36°C or above 38°C, or when white blood cell count 
is less than 4,000 cells/mm3 or greater than 12,000 cells/mm3 and a new antibiotic is added and 
continues for at least four days along with an oxygenation change (CDC, 2014). 
Possible VAP is defined as occurring on or after calendar day three of mechanical 
ventilation and within two calendar days before or after the onset of worsening oxygenation, 
when one of the following criteria is met: 1) Gram stain evidence of purulent pulmonary 
secretions, or; 2) a pathogenic pulmonary culture in a patient with IVAC (CDC, 2014).  
Probable VAP is defined as occurring on or after calendar day three of mechanical 
ventilation and within two calendar days before or after the onset of worsening oxygenation, 
when one of the inclusion criteria in Table 1.1 is met (CDC, 2014).  
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Table 1.1 
Inclusion Criteria for Probable VAP 
Criterion Requirements 
1 Gram stain evidence of purulent pulmonary secretions   
AND one of the following: 
 Positive culture of endotracheal aspirate, ≥ 105 CFU/ml or equivalent 
semi quantitative result 
 Positive culture of bronchoalveolar lavage, ≥ 104 CFU/ml or equivalent 
semi quantitative result 
 Positive culture of lung tissue, ≥ 104 CFU/ml or equivalent semi-
quantitative result 
 Positive culture of protected specimen brush, ≥ 103 CFU/ml or 
equivalent semi-quantitative result 
2 One of the following (without requirement for purulent respiratory secretions): 
 Positive pleural fluid culture (where specimen was obtained during 
thoracentesis or initial placement of chest tube and NOT from an 
indwelling chest tube) 
 Positive lung histopathology 
 Positive diagnostic test for Legionella spp. 
 Positive diagnostic test on respiratory secretions for influenza virus, 
respiratory syncytial virus, adenovirus, parainfluenza virus. 
  
 
 
 
PREVENTING VAE 5 
Statement of Problem 
  Despite advances in knowledge about management of mechanically ventilated patients, 
VAP remains the most frequent infection among patients hospitalized in intensive care units 
(ICU). It is a nosocomial infection that develops within 48 hours of establishing mechanical 
ventilation and is caused by pathogens that were not present in the lungs at the time of (Davis, 
2006; Horan, Andrus, & Dudeck, 2008). 
Mechanical ventilation by means of endotracheal intubation is one of the most common 
interventions implemented in the intensive care unit. Mechanical ventilation is also a mainstay of 
supportive therapy for patients with acute respiratory failure. It is estimated that approximately 
33% of patients admitted into the ICU are intubated with 24 hours of admission and account for 
a disproportionately high share of total cost of ICU treatment (Dasta, McLaughlin, Mody, & 
Piech, 2005). It is also estimated that ICU beds account for less than 10% of the total hospital 
beds in United States. However, they account for one third of total inpatient costs, an estimated 
national cost of $27 billion (Chalfin, Cohen, & Lambrinos, 1995; Dasta et al., 2005; Talmor, 
Shapiro, Greenberg, Stone, & Neumann, 2006). One study conducted from October 2008 
through December 2009, concluded that the mean hospitalization costs attributable to 
mechanical ventilation was $59,770 and for mechanically ventilated adults diagnosed with VAP, 
that cost was $99,598 (Kollef, Hamilton, & Ernst, 2012). This represents an additional cost of 
$40,000. 
Endotracheal intubation, a means of mechanical ventilation, is a necessary health care 
intervention to support respiration in patients who are unable to maintain adequate tissue 
oxygenation. The endotracheal tube bypasses several physiological barriers to respiratory tract 
infection, including the lips, epiglottis, cilia and mucus secreting cells.  As a result, VAP is a 
potential outcome for nearly all patients who have undergone endotracheal intubation.  
Etiology. Ventilator-associated pneumonia is caused primarily through the aspiration of 
oropharyngeal pathogens into the lungs as well as through cross contamination of bacteria 
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introduced into the oropharyngeal cavity by healthcare workers and microflora on the 
endotracheal tube (Hutchins, Karras, Erwin, & Sullivan, 2009; Meherali, Parpio, Ali, & Javed, 
2011; Nelson & Steinhoff, 2014, p. 562). Since the endotracheal tube bypasses normal 
defenses by holding the mouth, epiglottis and vocal chords in open positions, pathogens are 
able to pass into the lungs unopposed by normal defenses. Furthermore, ineffective oral care, in 
conjunction with unintended contact with contaminated environmental items during 
hospitalization, predisposes patients to nosocomial infections. Infection of the lower respiratory 
tract typically arises from aspiration of secretions, colonization of the oral-gastric tract, or use of 
contaminated equipment. Thus, the colonization of the oral cavity and the oropharynx directly 
correlates with the causative agents of VAP. 
Pathogenesis. The pathogens that commonly colonize pulmonary parenchyma in 
mechanically intubated patients are endemic to the ICU environment (Klompas, Kleinman, & 
Murphy, 2014). These microorganisms utilize a vast array of virulence factors, which are readily 
transmitted between each other to induce inflammation, tissue destruction and cell death. 
Furthermore, many microorganisms have developed mechanisms that allow them to evade 
detection by the host immune system and penetration by antimicrobial medications (Thomas, 
2013). 
Endotracheal intubation is associated with increased accumulation of dental plaque, oral 
debris, and biofilm; deterioration of mucous membranes, and colonization with respiratory 
pathogens (Fourrier, Duvivier, Boutigny, Roussel-Delvallez, & Chopin, 1998; Needleman et al., 
2012). Consequently, the pathogenesis of ventilator-associated events is a function of the 
myriad complex relationships between pathogen, host and environment. These relationships will 
be further discussed in chapter 2 of this EBP project report.  
Need for Project. The sites of implementation of this EBP project were four hospitals 
within a medium sized health care system operating in the Midwest. Each of these hospitals has 
a nursing procedure that identifies accepted and expected practices for providing oral care to 
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patients with mechanical ventilation, which include the use of several evidence-based 
interventions. These include mechanical brushing with chlorhexidine gluconate, head of bed 
elevation, subglottic suctioning and periodic sedation vacations with weaning readiness 
assessments. 
Because there had been an increase in the incidence of VAP at one of these facilities, 
the critical care nurse manager and clinical nurse specialist identified the need to audit 
compliance with the facility’s oral care nursing procedure. They discovered that oral care using 
the standardized supplies was not being performed as expected. Furthermore, while routine 
nursing assessments of overall health status were being performed according to nursing policy, 
oral health assessment was not included in the policy. Therefore, leaders at the four project 
sites identified a clear need to provide staff education about oral care and to revise their oral 
care protocol to include evidence-based interventions for routine oral health assessment.  
Documentation of oral health assessment gives nurses a framework to evaluate the 
extent of oral biofilm development to observe improvement or worsening of oral health over time 
and to intervene in a timely manner to prevent the precursors to VAE. Biofilm can be effectively 
fragmented by use of the force of mechanical brushing in conjunction with chlorhexidine 
gluconate solution (Nicolosi, del Carmen Rubio, Martinez, González, & Cruz, 2014). When the 
assessment is documented on a grid or chart, it facilitates the nurse’s recognition of trends 
toward improving or worsening oral health (Ames et al., 2011; Ridley & Pear, 2008). 
Purpose of the EBP project 
The purpose of this EBP project was to implement an evidence-based oral care protocol 
for mechanically ventilated adults to decrease the incidence of ventilator-associated events. The 
goal of this EBP project was to answer the clinical question: Among mechanically ventilated 
patients, how does the implementation of an oral care assessment guideline combined with a 
mandatory staff education program affect the incidence of ventilator associated events (VAE) 
when compared to standard care over a four month period? 
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This project incorporated strategies to: (a) identify evidence-based practices to prevent 
VAE using a protocol-based approach; (b) incorporate standardized oral health assessment into 
the current facility-approved oral care nursing procedure; (c) educate critical care nurses 
regarding facility-approved oral care procedures for patients with mechanical ventilation; (d) 
provide ongoing education at the bedside to support critical care nurses’ use of the oral health 
assessment tool; and (e) evaluate the effectiveness of staff oral care education and routine oral 
health assessment on the incidence of VAE. Because oral plaque and biofilm tend to occur 
together, observed reductions in plaque should correspond with reductions in biofilm (Nelson & 
Steinhoff, 2014). 
Significance of the project 
Ventilator-associated events are common conditions in mechanically ventilated patients. 
They are associated with clinically and economically devastating consequences, and the 
incidence has not improved despite a growing body of evidence to support VAP prevention 
interventions. Implementation of these guidelines using a translational science theoretical 
framework is necessary to ensure their adoption in clinical practice.  
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CHAPTER 2 
REVIEW OF LITERATURE 
Ventilator-associated events (VAE) encompass a variety of clinical conditions that occur 
in people requiring mechanical ventilation, including infectious and non-infectious complications 
of endotracheal intubation. Those susceptible to VAE represent a specialized population within 
the health care system with risk factors for VAE that are avoidable or can be minimized through 
evidence-based nursing interventions. This first section of this chapter synthesizes the current 
literature regarding the relationship between hospital-acquired infections, such as VAE, and the 
pathobiological mechanisms and clinical features of VAE from a pathophysiological perspective. 
The second section of this chapter will apply the Epidemiological Triangle of Infectious Disease 
to discuss complex factors such as agent, host, and environmental characteristics as they relate 
to clinical causality in the development of ventilator-associated infections. Finally, the third 
section of this chapter will propose that Everett Rogers’ Model of Diffusion of Innovations should 
guide this project’s evidence-based nursing interventions to prevent ventilator associated 
conditions and pneumonia among mechanically ventilated critically ill adults within the critical 
care setting.  
Summation of Current Literature 
 Healthcare associated infections (HAI), such as VAP, are common but preventable 
infectious illnesses that often result in increased morbidity, mortality, and additional medical 
care costs generated both in the hospital stay during which the preventable event occurs and 
during subsequent health care encounters that might not have otherwise been necessary 
(Pronovost et al., 2006). Since HAIs pose a significant health care problem to patients, 
clinicians, organizations and governments, prevention of HAIs has attracted increased visibility 
from regulatory agencies, healthcare organizations, healthcare personnel, and patient advocacy 
groups (Affordable Care Act, 2010; American Thoracic Society, 2005; CDC, 2004, 2014; ICSI, 
PREVENTING VAE 10 
2011; McKibben et al., 2005; Shi et al., 2013; Yokoe et al., 2014). Consequently, numerous 
initiatives have been enacted at state and national levels, by the Centers for Medicare and 
Medicaid Services (2013), to increase HAI transparency by requiring healthcare organizations to 
report HAI rates. In addition, healthcare guidelines and policy initiatives are tying prevention of 
HAIs to hospital reimbursement.  
Ventilator-Associated Pneumonia 
 Ventilator-associated pneumonia (VAP) is one of the most common hospital-acquired 
infections. It can develop in any patient on a ventilator, yet most occurrences are seen in 
intubated or ventilated patients after 48 hours. In these cases, the ventilator itself, or the 
process of intubation, acts as a source of direct entry for pathogens to gain access to the lungs 
(Alhazzani, Smith, Muscedere, Medd, & Cook, 2013; Barbier, Andremont, Wolff, & Bouadma, 
2013; Shi et al., 2013). Despite advances in techniques for the prevention and management of 
VAP in mechanically ventilated patients, VAP remains the most frequent infection among 
patients hospitalized in intensive care units. Ventilator-associated pneumonia is a nosocomial 
infection that may develop following 48 hours of establishing mechanical ventilation mechanical 
ventilation and is caused by pathogens that were not present at the time of intubation (Davis, 
2006; Horan, Andrus, & Dudeck, 2008). 
Ventilator associated conditions continue to occur as defined by the new specific ICD-9 
code and are associated with a significant resource utilization burden, which underscores the 
need for cost-effective interventions to minimize the occurrence of these complications. The true 
incidence of VAP is difficult to determine as surveillance definitions have changed since January 
2014. However, more recent clinical surveys suggest that the point prevalence is 9% to 27% 
among all intubated patients (Dudeck et al., 2011). The newer classification of VAP as a 
subtype of VAE will likely improve the accuracy of these estimates. According to Klompas, 
Kleinman, and Murphy (2014), the mortality attributable to VAP is estimated to be approximately 
10%, but varies considerably across ICU populations (Pereira et al., 2015).  
PREVENTING VAE 11 
Based on the timing of onset, associated patient risk factors, and patient exposure, VAP 
can be divided into early-onset or late-onset. Early onset VAP occurs in approximately one third 
of cases usually within three to five days following intubation. The main cause is attributed to 
pathogens (Staph. pneumoniae, H. influenzae and anaerobes of the oral cavity) with a favorable 
pattern of antibiotic sensitivity. Late onset VAP occurs in approximately two thirds of cases and 
is often caused by exposure to multidrug-resistant (MDR) pathogens such as Staph. aureus, P. 
aeruginosa, Enterobacteriaceae and A. baumannii, which are endemic to most ICU units 
(American Thoracic Society, 2005). Drug resistant pathogens are responsible for greater 
morbidity, prolonged ICU length of stay (LOS), and longer duration of ventilation, with estimated 
additional costs exceeding US$40,000 per occurrence (Kollef, Hamilton, & Ernst, 2012).  
Although VAP is the most studied VAE type, it is important for policy and financial 
reasons to focus on preventing all types of VAE. The next section will describe the 
pathophysiological features of oral cavity, that when invaded, increase the host’s susceptibility 
for the development of VAE.  
Pathophysiology of the Oral Cavity 
Mucosal Immune System. The development of oral biofilm is influenced by the 
immunological milieu in the oral cavity (Cutler & Sluman, 2014; Prendergast, Kleiman, & King, 
2013). The host’s mucosal immune system is of critical importance particularly due to its 
adaptive nature in protecting the host’s mucosal surfaces. The mucosal immune system 
consists of sentinel secondary lymphoid tissue, which is rich in antigen-presenting cells, CD4+ T 
cells and B cells, which are present at the portals of entry to the body and extend to the 
respiratory system, digestive tract, the genitourinary tract, eyes and mammary glands (Cole, 
Wirth & Bowden, 2013). Secretory immunoglobulin A (SIgA) antibodies, primarily found on 
mucosal surface layers and in exocrine secretions, are protective through a non-inflammatory 
mechanism that neutralizes toxins and facilitates removal of endogenous oral microorganisms 
which may be detrimental to the host due to unimpeded proliferation (Cole et al., 2013). This 
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protective mechanism is carried out by salivary flow of secretions which block the adhesion or 
aggregation to epithelia receptors on microbial cells thus inhibiting microbial growth and 
mediating direct bacterial lysis (Cerrutti & Rescigno, 2008; Cole et al., 2013). 
Oral Pharyngeal Structures. Motility of saliva is associated with the pharynx and 
esophagus. From the mouth, the uppermost portion of the pharynx is the nasopharynx; it 
extends from the posterior upper surface of the palate, posteriorly to the nasal fossa, to the 
occipital bone (Sherwood, 2010, p. 463). The nasopharynx is surrounded by the 
salingopharyngeal fold and tubal tonsils, which become inflamed when infected. It also contains 
the adenoids and eustachian tube openings that provide drainage for lymphatic fluids into the 
throat, nose, and ears (Sherwood, 2010, p. 463). The adenoids function to detect and destroy 
pathogens entering the nasopharynx via the air. The uvula, a conic projection from the posterior 
edge of the middle of the soft palate, is instrumental during swallowing and functions to close off 
the nasopharynx to prevent foodstuff from back flowing into the nasal cavity (Sherwood, 2010, 
p. 463).  
 Oropharynx. The next portion of the pharynx is the oropharynx. It is positioned behind 
the oral cavity and extends from the posterior aspect of the soft palate to the epiglottis. 
Additional oropharynx structures include the epiglottic vallecula, palatine and lingual tonsils, and 
the epiglottis (Marieb & Mallatt, 1997). The oropharynx aids in swallowing, respiration and as an 
immunological defense within the host. During swallowing, the epiglottis closes over the glottis 
to prevent aspiration into the airway (Marieb et al., 1997). Immunologically, the palatine tonsils, 
located laterally in the walls of the fauces, are responsible for T-cell activation following 
microbiological exposure (Marieb et al., 1997; Sherwood, 2010).  
 Laryngopharynx. The inferior-most portion of the pharynx is the laryngopharynx. Like 
the oropharynx, it facilitates digestion and respiration. It is lined with stratified squamous tissue 
and extends from the hyoid bone to the larynx, inferior to the epiglottis. Continuous with the 
esophagus, the laryngopharynx bifurcates into the larynx where sound is produced (Marieb & 
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Mallatt, 1997; Sherwood, 2010). At the most inferior aspect of the laryngopharynx, the epiglottis 
and vocal cords serve as physical barriers to potential pathogens entering the lower respiratory 
tract. 
Trachea. The trachea is lined with cilia and mucus-secreting goblet cells, which trap and 
carry potential pathogens from the lower respiratory tract to the mouth where they can be 
expectorated or swallowed (Marieb & Mallatt, 1997; Sherwood, 2010). The trachea bifurcates 
into two bronchi that lead into the right and left lungs. Both lungs are contained within the rib 
cage and are positioned superiorly to the diaphragm. In the patient without an artificial airway, 
potential pathogens are unlikely to reach the lungs unless they are particularly virulent or the 
host has nonfunctional protective mechanisms in the mouth, pharynx, larynx, and trachea due to 
structural disease (e.g. throat cancer), immunosuppression, or mechanical failure of the 
epiglottis from neurological dysfunction (e.g. cerebrovascular accident). The bronchial walls 
contain mucus producing goblet cells and participate in the mucociliary transport system, 
similarly to the trachea. However, excessive mucus production can easily obstruct airflow 
through the relatively smaller bronchi. Coughing facilitates the removal of excessive mucus in 
the host with an intact cough reflex.  
Epithelium. The host and environment interface in two major ways, both of which offer 
protection to the host from potential agents in the environment. The skin and nails cover the 
human body and have a surface area of approximately two square-meters. The mucous 
membranes, which line the gastrointestinal, respiratory, and urogenital tracts, cover a surface 
area in excess of 400 square-meters (Cerrutti & Rescigno, 2008). Constant interactions with 
micro- and macro-organisms occur on epithelial and mucosal portals of entry (e.g. 
gastrointestinal tract, respiratory and urogenital tracts). Physiological interaction with these 
microorganisms leads to colonization of epithelial and mucosal surfaces and this co-existence is 
largely commensal (Cole, Wirth & Bowden, 2013; Hansen, Gulati, & Sartor, 2010). However, 
when the protective functions of these tissues are compromised, exogenous bacteria invade the 
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nutrient rich environment of the human body and cause infectious disease to develop, often with 
deadly results (Hansen et al., 2010).  
Artificial Airway. An artificial airway, such as an endotracheal tube or tracheostomy 
tube, allows potential pathogens in the lower respiratory tract to evade mucociliary removal, and 
the use of sedating medication (which is extremely common in patients who are mechanically 
ventilated) or the presence of neurological impairment diminishes or inhibits the cough reflex. In 
these patients, the only remaining natural defense mechanism against infection is the host 
inflammatory response in the alveoli. This response consists of pre-existing alveolar 
macrophages and the recruitment of neutrophils to the alveoli through cytokine and complement 
activation and vasodilation of the alveolar capillaries. This host response is a powerful 
mechanism to destroy invading pathogens, but it is nonspecific and can cause life-threatening 
inflammatory injury within the alveoli. Clinical features of alveolar inflammation include 
respiratory distress, cyanosis, leukocytosis, fever, hypoxia, respiratory acidosis, and respiratory 
arrest. Radiographic evidence of widespread alveolar consolidation may be present. Oxygen 
therapy, antimicrobial medications, anti-inflammatory medications, chemical paralysis, and a 
variety of specialized mechanical ventilator settings can support respiration, but these therapies 
have severe clinical and economic consequences. Because artificial airways bypass nearly all 
host protective mechanisms, and the remaining mechanisms can be both ineffective and 
counterproductive, prevention and early identification of oral cavity colonization is of paramount 
importance in this population.  
Endotracheal intubation is associated with increased accumulation of dental plaque, oral 
debris, biofilms, deterioration of mucous membranes, and colonization by potential respiratory 
pathogens (Fourrier, Duvivier, Boutigny, Roussel-Delvallez, & Chopin, 1998; Needleman et al., 
2012). Consequently, the pathogenesis of VAE is a function of the myriad complex relationships 
between pathogens, host, and environment. Colonization of the oropharynx by potential 
respiratory pathogens contributes to VAE. Further, ineffective oral care, in conjunction with 
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unintended contact with contaminated environmental items during hospitalization, predisposes 
patients to nosocomial infections.  Infection of the lower respiratory tract typically arises from 
aspiration of secretions, colonization of the oral-gastric tract, or use of contaminated equipment. 
Thus, the colonization of the oral cavity and the oropharynx directly correlates with the causative 
agents of VAE. 
Oral Biofilm. The most common agents of VAE are the bacteria S. aureus, P. 
aeruginosa, Enterobacteriaceae and A. baumannii. These species express specialized virulence 
factors that enable a variety of survival advantages within the host, including: adherence to 
biomedical devices, direct physical damage to cells lining the respiratory tract, nutrient 
acquisition, resistance to antimicrobial medications, host immune factors, and development of 
protective microbial communities called biofilms (Brennan et al., 2004; Dubey & Ben-Yehuda, 
2011; Mohapatra, & Biswas, 2013).  
Genetic and phenotypic variability within oral biofilm pathogens leads to biodiversity and 
pathogenic genetic adaptation (Goulhen, Grenier, & Mayrand, 2003; Kumar, Mason, & Yu, 
2013). This process occurs through cell-cell communication, gene transfer via conjugation and 
plasmid exchange, and resistance to antimicrobial medications, heat, and gastrointestinal acid, 
according to Kumar and colleagues (2013). Genetic regulation allows oral microflora to express 
different characteristics within the oral cavity. This process confers advantages not only to other 
co-existing bacteria, but also to the human host in some cases (Kumar et al., 2013).  
Artificial Airways 
Patients with artificial airways are uniquely susceptible to respiratory tract infections. In 
patients without artificial airways, several structures and substances are present that prevent 
lower respiratory tract infection. Saliva in the oral cavity provides several protective mechanisms 
against infection, including physical removal of microorganisms through swallowing, a high 
concentration of immunoglobulin A and complement, and a liquid environment that prevents 
biofilm formation on dental enamel and oral mucous membranes. In addition, saliva also 
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contains numerous non-specific protective factors such as lysozyme, lactoferrin, histatins, 
mucins and peroxidases that have a protective function at mucosal surfaces. Moreover, salivary 
flow buffers oral pH, thus neutralizing acid production in order to maintain dental and mucosal 
integrity and facilitate oral particulate clearance (Cerrutti & Rescigno, 2008; Cole, Wirth & 
Bowden, 2013; Hajishengallis, 2014).  
Statistically, up to one-third of critically ill patients are susceptible to developing a lower 
respiratory infection such as VAP (Armstrong & Mosher, 2011; DeKeyser Ganz et al., 2009). It 
is not possible to determine which critically ill patients will develop hospital acquired pneumonia 
as a result of bypassing their physiological protective structures without assessing their oral 
cavity. It has been determined that poor oral health among mechanically ventilated patients 
increases the bacterial virulence of oropharyngeal secretions that lead to the subsequent 
development of nosocomial infections (Paju & Scannapieco, 2007) However, despite of the 
American Association of Critical Care Nurses (AACN) recommendations advocating for oral 
care, fewer than 44% of critical care nurses report brushing teeth (DeKeyser Ganz et al., 2009). 
Therefore, translation of evidence-based oral care practice guidelines is important to improving 
patient outcomes for critically ill, mechanically ventilated, care-dependent patients (CDC, 2014; 
ICSI, 2011; Shi et al., 2013).  
Oral Hygiene 
Acutely ill patients are reliant upon nursing staff to perform oral hygiene. However, 
studies report that staff are lacking in appropriate knowledge regarding the tools to adequately 
and consistently assess and provide oral care (Ames et al., 2011; Chan, Lee, Poh, Ling, & 
Prabhakaran, 2011; DeKeyser Ganz er al., 2009; Muscedere et al., 2011; Nicolosi et al., 2014; 
Prendergast, Kleiman, & King, 2013; Richards, 2013; Ross & Crumpler, 2007). Oral care of the 
critically ill hospitalized patient is an essential component of nursing care; therefore it is a 
nursing responsibility. This care is particularly important to mechanically ventilated patients 
when both disease and treatments lead to the deterioration of the oral membranes and teeth. 
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This deterioration is primarily due to the marked decline in salivary secretions resulting from 
disease processes and adverse effects related to medication regimens (Holmes & Mountains, 
1993). Oral care is an important intervention that can augment the progression of microbial 
proliferation in the mouth (Garcia et al, 2009). A thorough oral assessment is required to provide 
clinicians with the patient’s baseline oral health status, monitor response to therapies, identify 
new problems, and to decrease the risk of having commensal microflora with the oral cavity 
from potentially proliferating to a pathogenic state thus increasing the risk of pneumonia as a 
result of intubation or aspiration. 
Oral Assessment Role 
Human disease does not arise in a vacuum nor does it occur by chance. Epidemiology, 
the study of the determinants and distribution of disease, forms the research basis of public 
health interventions, including those that are implemented in health care facilities to prevent 
nosocomial infections. Epidemiology is based on two fundamental principles that state that 
disease does not occur at random and that disease is preventable (Nelson, 2014). Although 
some diseases are genetic in origin, most human diseases, particularly infectious diseases such 
as those included in ventilator-associated events, are caused by events, clinical conditions, host 
characteristics, or a complex combination of these factors. Research methods, driven by an 
epidemiological framework that links the host, an agent, and the environment, can be used to 
evaluate the different factors or characteristics that favor the development, acquisition, and 
transmission of infectious disease and its burden on populations. Furthermore, epidemiological 
studies can be used to evaluate these multifactorial relationships in an effort to alter or intervene 
in the disease cycle (Gange & Golub, 2014).  
In summary, the mouth is a window to the overall health of the patient. Poor oral health 
represents a general balance among host’s physiology, ongoing disease processes, and 
adequate oral care aimed at preventing oral biofilm build-up, aspiration, and decompensation. 
Oral deterioration and respiratory decompensation occurs when the balance is altered by 
PREVENTING VAE 18 
changes in the interacting relationships among the stated factors. Prevention is concerned with 
maintaining or initiating a balance of these factors to reduce the likelihood of oral infectious 
processes that may lead to VAE development. The next section will describe the features that 
agent, host, and environment as they relate to the Epidemiological Triangle of Infectious 
Disease. 
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 Figure 2.1. Epidemiological Triangle 
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Epidemiological Triangle of Infectious Disease 
The Epidemiologic Triangle (Figure 2.1) is a conceptual framework that can be used to 
model the transmission dynamics of an infectious disease (Friss & Sellers, 2014). The three 
essential characteristics of the Epidemiological Triangle include the susceptible host, infectious 
agent, and the environment. These three elements are depicted in Figure 2.1. The 
Epidemiological Triangle describes disease by identifying the patterns of acquisition/exposure, 
transmission, and risk factors inherent to a disease, in order to predict and thereby control or 
prevent its transmission among a population within a particular setting (Friss & Sellers, 2014; 
Gange & Golub, 2014).  The epidemiological framework will guide the explanation of how agent, 
host, and environmental factors jointly contribute to the development of VAE.  
Agent 
Within the epidemiologic triangle, an agent is a factor whose presence, absence, excess 
or deficit is necessary for a particular disease or injury to occur. Bacteria, protozoa, and viruses 
are examples of agents that have the potential to cause infectious disease depending on their 
pathogenicity, virulence and infectivity. The pathogenicity of an organism is its ability to cause 
disease (Nelson, 2014, p. 27). Virulence is the degree of pathogenicity within a group or species 
of microorganisms as indicated by case fatality rates and/or the ability of the organism to invade 
the tissues of the host (Nelson, 2014). Infectivity refers to the ability of a pathogen to establish 
an infection (Nelson, 2014). These terms attempt to describe various aspects of the agent’s 
impact on infectious disease. By measuring the pathogenicity, virulence, and infectivity of a 
microorganism, clinicians can reduce the impact of the agent on the susceptible host (Gange & 
Golub, 2014, p. 44). 
Infective agents that exist and flourish within protective biofilms have been the source of 
disease throughout evolutionary history. Biofilms affect the course and pathogenesis of a 
number of systemic diseases including diabetes, cardiovascular disease, preterm birth, and 
VAP (Igari, Kudo, Toyofuku, Inoue, & Iwai, 2014). Biofilms form tightly on biological and 
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synthetic surfaces. This bacterial structure provides advantages and protection for species such 
as S. aureus, P. aeruginosa, S. mutans and Enterobacteriaceae, from the host immune system 
and from antimicrobial penetration (Chestre & Fagon, 2002). Biofilm formation enables 
planktonic single celled microorganisms to adhere to each other and to a variety of moist 
surfaces such as living tissues, indwelling medical devices, water system piping and natural 
aquatic systems. This dynamic adherence process, of highly differentiated organisms, is 
triggered in response to environmental changes, forming matrix-enclosed bacterial populations 
in an effort to facilitate survival within adverse environments (Høiby, Bjarnsholt, Givskov, Molin, 
& Ciofu, 2010; Nobbs, Jenkinson, & Jakubovics, 2011). After attachment, bacteria produce a 
very sticky substance known as extracellular polymeric substance that traps nearby planktonic 
bacteria and cements them into the biofilm, a process known as coadhesion.  
As biofilm grows, nearby planktonic bacteria bind together through a process known as 
coaggregation in preparation for adhesion to a larger microenvironmental matrix structure 
(Huang, Li, & Gregory, 2011). These processes form three important survival advantages for 
bacteria in the oral cavity. First, bacteria that are tightly aggregated to one another and adhered 
within a biofilm are no longer influenced by the flow of saliva and cannot be swallowed or 
otherwise removed from the oral cavity (Hannig & Hannig, 2009; Huang et al., 2011). Second, 
bacteria in close contact with other bacteria can freely exchange plasmids and pathogenicity 
islands that encode for more pathogenic virulence factors (Hannig et al., 2009; Hojo, Nagaoka, 
Ohshima, & Maeda, 2009; Huang et al., 2011). In fact, even commensal non-pathogenic 
bacteria in the oral cavity can become highly virulent within a biofilm with other highly virulent 
bacteria. Third, the extracellular polymeric substance is impermeable to antimicrobial molecules 
and soluble immune factors such as the complement system and immunoglobulins (Huang et 
al., 2011). These important features of biofilms allow pathogens to thrive in the oral cavities of 
patients with artificial airways.  
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Aggressive and ongoing interventions that focus on removal of bacteria from the artificial 
airway, dental enamel, and mucosal membranes are necessary to prevent the initial processes 
of biofilm formation. Bacterial communication, within and between species, occurs through 
molecular biochemical signaling within the oral biofilm matrix. The signal molecules, termed 
autoinducers (AI), allow both monospecies and multispecies communities to synchronously 
regulate gene expression (via a positive feedback loop), and therefore behavior, on a 
community-wide scale (Huang, Li, and Gregory, 2011; Li & Nair, 2012; Mohapatra, & Biswas, 
2013). The process of cell-cell communication in bacteria, known as quorum sensing (QS), 
plays a critical role in shaping the composition of oral microflora by regulating gene expression 
in a cell-density-dependent manner (Huang et al., 2011; Li & Nair, 2012). Bacteria use QS to 
coordinate cellular functions such as biofilm formation, virulence, and antibiotic resistance, 
based on the local density of the bacterial population, according to Li and Nair (2012). When a 
biofilm becomes too densely populated, pathogens near the surface of the biofilm convert to 
their planktonic form and leave the biofilm in search of a new location within the oral cavity or 
respiratory tract.  
These pathogens, which commonly colonize pulmonary parenchyma in mechanically 
intubated patients, are endemic to healthcare settings as shown by Klompas and colleagues 
(2014). In hospitals, biofilms form on durable medical equipment (i.e. mechanical ventilators) 
enabling pathogenic organisms to persist as reservoirs and readily spread to patients. These 
microorganisms utilize a vast array of virulence factors, which are readily transmitted between 
each other within biofilms, to induce inflammation, tissue destruction, and cell death. Biofilm can 
develop both in the community environment and in the healthcare setting. In hospitals, biofilms 
form on medical equipment enabling pathogenic organisms to persist as reservoirs and readily 
spread to patients. Inside the host, biofilms allow pathogens to subvert innate immune defenses 
and are thus associated with long-term persistence. As these pathogens reproduce, they 
exchange genetic material, leading to genetic and phenotypic variability, as well as antimicrobial 
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resistance to infectious agents within the oral biofilm matrix (Huang, Li, and Gregory, 2011; 
Kumar, Mason, & Yu, 2013).  
Genetic variability is a measure of the tendency of individual genotypes in a population 
to vary from one another by means of genetic exchange (Cummings & Lessler, 2014). In 
essence, genetic variability leads to genetic biodiversity within a population (Frankham, 2005). 
Genetic and phenotypic variability is essential for populations to adapt to environmental 
changes. This is true in nature, as well as in the human mouth. In nature, two historical 
occurrences illustrate this adaptation method. The genetic variability allowed pathogens to 
spread and transmit over time to millions of people (Cummings et al., 2014). Furthermore, 
because each of these adaptations is associated with a simultaneous change in antigenic 
structure, the host’s immune system becomes less effective at recognizing the pathogen. This 
leads to uninhibited microbial reproduction and damage to host cells.  
In summary, the agent’s adaptability, virulence, resistance and stealth allows for its 
pathogenicity. Pathogens have the ability to communicate and adapt to changing environments 
allowing them to survive and develop highly virulent characteristics over time due to genetic and 
phenotypical variability.  
Host 
A host is the individual susceptible to the infectious agent. In a health care setting, the 
host may be a patient, visitor, or health care worker; although most of the emphasis of health 
care associated infection prevention is placed on the patient. When the host has adequate 
protection against infectious agents, it is less susceptible to infection. A host’s innate defenses 
(i.e. normal flora, skin, epiglottis, sphincters, complement, neutrophils, macrophages) and 
acquired defenses (e.g. antibodies, lymphocytes) provide this protection, but they can be 
weakened by age, medical comorbidities, poor nutrition, genetic mutations, medications, 
invasive devices or procedures, and the patient’s environment (Margolick, Markham, & Scott, 
2014; Nelson & Steinhoff, 2014).  
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Individuals with invasive devices, such as artificial airways, are at particularly high risk 
for the development of health care associated infections once they are exposed to an infectious 
agent. Invasive biomedical devices are inserted into the host to facilitate medical care, but they 
bypass one or more primary lines of host defense. In the case of an artificial airway, the 
epiglottis is maintained in an open position, which permits bacteria and yeast from the oral 
cavity to migrate into the respiratory tract causing infection. Furthermore, an invasive biomedical 
device provides a surface to which infectious agents, particularly bacteria, can adhere, form 
biofilm, and more easily migrate into the lungs (Thomas, 2013).  
Environment 
The transmission of infectious agents from contaminated sources external to the host 
can lead to the development of a hospital acquired infection (HAI). The environment plays an 
important role in infectious disease epidemiology. A host’s environment is comprised of the 
host’s physical surroundings and includes inanimate objects, air, water, and human contact 
(Coffin et al., 2008; Mehta et al., 2014; Paitoonpong, Wong, & Perl, 2014). Particularly in the 
intensive care unit, environmental factors, such as medical equipment, beds, furniture, and 
other persons, harbor and promote the spread of pathogens (De la Fuente-Núñez, Reffuveille, 
Fernández, & Hancock, 2013; Paitoonpong et al., 2014).  
Many virulence factors expressed by pathogens, including adhesions, pili and fimbriae, 
facilitate tight adherence of the pathogen to both inanimate and live surfaces. Moreover, some 
bacteria can produce spores, which contain viable pathogen DNA and permit prolonged 
pathogen survival within even the most hostile environmental surroundings.   
Pathogens can be transmitted in a variety of ways through the environment, including 
through direct physical contact, droplet nuclei in the air and direct inhalation of the organism. 
Organisms such as those that cause VAE are spread primarily through direct physical contact. 
Humans live in continuous interaction with their environment. Patients with an artificial airway, 
especially if neurologically impaired or pharmacologically sedated, are particularly susceptible to 
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environmental influences. In the critical care environment, these patients reside in a physical 
environment that is heavily contaminated with a diverse ecology of highly virulent 
microorganisms. Because these patients require frequent and usually hands-on care due to 
their critical illness, they are often brought into direct physical contact with these 
microorganisms. 
Medications. Medications can increase the risk for infection in patients with artificial 
airways. The use of highly potent antimicrobial medications to treat infections elsewhere in the 
body can have important consequences in the pulmonary tract. First, broad-spectrum antibiotics 
can have bactericidal effects on normal non-pathogenic flora that would otherwise offer the host 
protection against the proliferation and migration of pathogenic flora. Second, inappropriate 
antimicrobial use can lead to antimicrobial resistance. Anti-inflammatory medications, including 
glucocorticoids and chemotherapeutic agents, suppress several immune mechanisms in the 
host. In patients with artificial airways, these immune mechanisms are among the only defenses 
available to prevent lower respiratory tract infections. When high doses of anti-inflammatory 
medications are given, the alveolar inflammatory response is blunted and pathogens are 
allowed to establish permanent colonies within the lung parenchyma. Guidelines have been 
published that facilitate appropriate use of antimicrobials and anti-inflammatories (Bassetti, 
Taramasso, Giacobbe, & Pelosi, 2012), but adherence to these guidelines has not been 
evaluated. Regardless, medications are an important part of the host’s environment, particularly 
in the critical care unit, and clinicians must be cautious to avoid inappropriate medication use.  
Mechanical Ventilation. The mechanical ventilator and its circuitry are important 
reservoirs of respiratory infection in the critical care unit. The ventilator must be properly 
maintained based on the number of hours of use. Condensate forming within the breathing 
circuit can also facilitate bacterial growth. The ventilator surfaces must be cleaned and the 
breathing circuit and endotracheal tube must be discarded or appropriately sterilized between 
patients. The breathing circuit and endotracheal tube are constructed of plastic and should be 
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sterilized or replaced in accordance with the manufacturer’s recommendations. Mechanical 
ventilators may also contain humidifiers that must be cleaned and refilled with water from a 
suitable uncontaminated source. There is also a risk of trauma to the oral mucosa during 
intubation or alveolar distention during positive pressure ventilation, either of which could further 
compromise the host’s natural defenses.  
 Staff. Nurses, physicians, and respiratory care practitioners are important within the 
mechanically ventilated host’s environment. The nurse has frequent and prolonged direct 
contact with the host during bathing, repositioning, medication administration, and clinical 
procedures. The physician has less frequent or prolonged exposure to the host than nurses, but 
contributes significantly to the host’s risk for respiratory tract infections through initial placement 
of the artificial airway, prescription of ventilator settings and medications, and ordering 
diagnostic studies to monitor for evidence of infection. The respiratory care practitioner also has 
frequent, though usually brief, direct contact with the host. However, physical contact between 
the respiratory care practitioner and host involves several opportunities to introduce potential 
pathogens into the ventilator circuit or other aspects of the host’s environment.  
Clinicians involved in the care of mechanically ventilated patients must be 
knowledgeable of the basic concepts of infectious disease epidemiology and proficient with their 
application to this population (Gange & Golub, 2014). Using an epidemiological perspective, in 
particular, the Epidemiological Triangle can be a useful strategy to frame quality improvement 
projects related to the prevention of VAE. Evidence-based interventions addressing all three 
aspects (i.e. agent, host, and environment) must be used to accomplish the goal of eradicating 
VAEs in the mechanically ventilated population.  
Literature Search Strategy 
A comprehensive literature search occurred electronically to find the best evidence-
based research relevant to oral health and VAE prevention. The following electronic databases 
were searched: Cumulative Index to Nursing and Allied Health (CINAHL), Cochrane Database 
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of Systematic Reviews, ProQuest, Medline, PubMed, Joanna Briggs Institute, and the National 
Guideline Clearinghouse. The search was limited to scholarly articles, published in English, 
since 2000 to ensure inclusion of classic articles. Search terms used for the literature search 
included: oral care and ventilator-associated pneumonia prevention, oral biofilm elimination, oral 
hygiene, oral assessment, and oral assessment tools. Boolean phrases “and” and “or” were 
used between words to produce a larger volume of search results. The literature reviewed 
included peer-reviewed journal articles, evidence-based practice articles, systematic reviews, 
and meta-analyses. Additionally, the bibliographies for relevant research articles were consulted 
to expand the literature search. Articles that were not clearly related to this EBP project, 
editorials, expert opinions, and commentaries were excluded from the search. 
Following the literature search, articles were reviewed for completeness and scope. 
Duplicate studies were eliminated and all remaining articles were appraised to evaluate their 
adequacy and transferability to this study. After thorough analysis, fifteen articles were selected 
for this project.  
Sources Examined for Relevant Evidence  
All studies that were chosen for inclusion addressed the standard of oral care, use of 
placebo or other products for oral care as control interventions and retained studies that 
reported rates of ventilator associated pneumonia as outcomes. In CINAHL, out of a total of 130 
possible articles four studies were appropriate for inclusion. A PubMed via EBSCO search 
yielded nine articles. Out of those nine, three articles were appropriate to this study. The 
remaining articles were discarded due to their lack of specificity to the subject under 
investigation. In the Cochrane Database of Systematic Reviews, a search revealed 96 articles 
and of those, eight meta-analyses addressed the clinical question. ProQuest yielded 13 
potential sources based on the key terms. Of those, only one research article addressed the 
clinical question. The remaining 12 articles did not meet inclusion criteria. Searches of the 
Joanna Briggs Institute database resulted in seven articles. Out of seven, two were selected for 
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inclusion into this study. Additionally, a search was done of the National Guideline 
Clearinghouse database and it resulted in 14 guidelines. Only one evidence-based guideline 
was appropriate for inclusion. The CONSORT Diagram in Figure 2.2 illustrates the flow of the 
process used to appraise the evidence in the literature. 
Following the literature search, nineteen articles were reviewed for completeness and 
scope. Duplicate studies were eliminated and all remaining articles were critiqued. After 
thorough examination, fifteen articles were selected for this project. The articles considered for 
review included systematic reviews, meta-analyses, randomized control trials (RCTs), quasi-
experimental studies, descriptive studies and a clinical practice guideline. 
Critical Appraisal of Evidence 
 The Australian government’s National Health and Medical Research Council (NHMRC) 
2005 classification system was utilized to appraise the level and quality of evidence for each 
selected article. Out of the fourteen articles selected for inclusion, eight were meta-analyses of 
RCTs (Level I); two were RCTs (Level II); one was a quasi-experimental study (Level III-1); and 
four case studies with pre-test and post-test outcomes (Level IV). Ten of the articles were rated 
“A” for overall high quality, three articles were rated at “B” for good quality, one article was rated 
“C” for satisfactory quality, and none were rated “D” for poor quality. A summary of the articles 
and their individual appraisal is presented on Table 2.1, which provides a summary of the 
authors, date of publication, level of evidence rating, and key finding related to the proposed 
EBP project.  
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Table 2.1 
Appraisal of Literature 
Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
Alhazzani et 
al., (2013) 
Level I  Systematic review of six randomized control trials (RCT) comparing different 
tooth brushing modalities (electric with manual) and chlorhexidine (CHX) use to 
usual oral care. 
 In four trials, there was a trend toward lower VAP rates (risk ratio [RR], .77; 95% 
CI, .50 to 1.21; p = .26). The only trial with low risk of bias suggested that 
toothbrushing significantly reduced VAP (RR, .26; 95% CI, .10 to .67; p = .006).  
 Use of chlorhexidine antisepsis seems to attenuate the effect of toothbrushing on 
VAP (p= .02).  
 One trial comparing electric vs. manual toothbrushing showed no difference in 
ventilator-associated pneumonia rates (RR, .96; 95% CI, .47 1.96; p = .91). 
 Toothbrushing did not impact on length of ICU stay, or ICU or hospital mortality. 
Ames et al., 
(2011) 
Level IV  Evidence summary to identify the best available tools, the modified Beck Oral 
Assessment Scale (BOAS) and the Mucosa-Plaque Score (MPS), for the oral 
assessment and evaluation of oral hygiene as a means of reducing oral 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
microflora that leads to the development of VAP. 
 CDC (2004) Level I  CDC offers (clinical practice guidelines) recommendations in the prevention and 
control of VAP. 
Gastmeier & 
Geffers, 2007 
Level I  Systematic review of 15 RCTs that identified multi-module programs for reducing 
VAP rates. The data lead to the conclusion that topical use of CHX for oral care 
is beneficial and subglottic secretion drainage may lead to delayed onset of VAP. 
Grap et al., 
(2011) 
Level II  This RCT tested an early intervention involving a single dose application of CHX 
by swab versus control (no swab) in an effort to reduce the incidence of VAP. 
 This study randomly assigned 145 trauma patients requiring endotracheal 
intubation to the intervention (5 mL CHX) or control group. VAP (Clinical 
Pulmonary Infection Score [CPIS] ≥ 6) was evaluated on study admission and at 
48 and 72 hours after intubation. 
 A significant treatment effect was found on admission to 48 hours (p = .020) and 
to 72 hours (p = .027).  
 The study concluded that an early, single application of CHX to the oral cavity 
significantly reduces CPIS and thus VAP in trauma patients. 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
Hutchins et 
al., (2009) 
Level IV  Descriptive study involving the implementation of an oral care intervention every 
four hours on mechanically ventilated adult patients.  
 The use of an oral care intervention led to an 89.7% reduction in the VAP rate in 
mechanically ventilated patients from 2004 to 2007. 
 The pre-implementation VAP rate in 2004 was 12.6 cases/1000 ventilator-days. 
After the implementation of the oral intervention the VAP rates decreased to 4.12 
VAP cases/days of ventilation x 1000 ventilator-days for May to December 2005, 
to 3.57 for 2006, and to 1.3 for 2007. 
 The study concluded that the use of an oral care intervention led to a reduction 
in the VAP rate among mechanically ventilated patients in this study.  
Hillier et al., 
(2013) 
Level I  This systematic review and meta-analysis of evidence comparing the effect of 
oral care practices, oral hygiene products and oral protocols on VAP incidence 
rates. 
 Review concluded that the implementation of an oral care protocol, ongoing 
nurse education, and evaluation were important in reducing the incidence of 
VAP. 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
ICSI (2011) Level I  Institute for Clinical Systems Improvement (ICSI) published evidenced based 
VAP prevention guidelines in conjunction with the National Guidelines 
Clearinghouse- (Guideline Summary NGC-8966). This systematic review 
identifies the best available evidence for recommendations in the prevention of 
VAP. The aims for this protocol are to eliminate VAP and to increase the use of 
the VAP bundles and order sets in the management of mechanically ventilated 
adult patients residing in the intensive care setting. 
Koeman et al.,  
(2006) 
Level II  The objective of this randomized, double blind, placebo-controlled clinical trial 
was to determine the effect of oral decontamination with CHX or CHX/COL on 
VAP incidence and time to development of VAP.  
 This study enrolled 385 patients into three arms of the trial. Baseline 
characteristics were comparable. The daily risk of VAP was reduced in both 
treatment groups compared with placebo: 65% (hazard ratio [HR] = .352; 95% 
CI, .160, .791; p=.012) for CHX and 55% (HR=.454; 95% CI, .224, .925; p= .030) 
for CHX/COL. 
 The study concluded that oral decontamination with CHX or CHX/COL reduces 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
the incidence of VAP. CHX/COL provided significant reduction in oropharyngeal 
colonization with both gram-negative and gram-positive microorganisms, 
whereas CHX mostly affected gram-positive microorganisms.  
Muscedere et 
al., 
(2011) 
Level I  Systematic review and meta-analysis of evidence comparing thirteen RCTs with 
a total of 2442 randomized patients. The RCT involved mechanically ventilated 
adults patients and compared standard endotracheal tube use with and without 
subglottic secretion drainage access and reported on the occurrence of VAP. 
 Of the 13 studies, 12 reported a reduction in VAP rates in the subglottic 
secretion drainage arm. 
 The overall VAP RR was .55 (95% CI, .46-.66; p < .00001) with no heterogeneity 
(I = 0%). The use of subglottic secretion drainage was associated with reduced 
intensive care unit length of stay (-1.52 days; 95% CI, -2.94 to -.11; p = .03); 
decreased duration of mechanically ventilated (-1.08 days; 95% confidence 
interval, -2.04 to -.12; p = .03), and increased time to first episode of ventilator-
associated pneumonia (2.66 days; 95% CI, 1.06-4.26; p = .001). There was no 
effect on adverse events or on hospital or intensive care unit mortality. 
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Levels of 
Evidence 
Key evidence and related findings 
Nicolosi et al., 
(2014) 
Level III-1  Quasi-experimental study comparing the use instructor led oral hygiene (tooth 
brushing) and oral rinses with .12% chlorhexidine gluconate (Group 1) to a 
historical control group (Group 2) in the prevention of VAP among cardiovascular 
surgery patients. 
 Dentist provided instruction and supervised oral hygiene with tooth brushing and 
chlorhexidine oral rinses.72 hours prior to cardiovascular surgery. 
 There was a lower incidence of VAP (2.7% [95% CI  .7-7.8] vs 8.7% [95% CI 
4.9-14.7], P = .04) and a shorter hospital length of stay (9 ± 3 d [95% CI 8.5-9.5] 
vs 10 ± 4 d [95% CI 9.4-10.7], P = .01) observed in the intervention group.  
 The risk for developing pneumonia after surgery was 3-fold higher in control 
group (3.9, 95% CI 1.1-14.2). 
 The study concluded that supervised oral hygiene with chlorhexidine proved 
effective in reducing the incidence of VAP. 
Prendergast 
et al (2013) 
Level IV  A descriptive study evaluated the effectiveness of implementing two oral 
assessment tools. The Bedside Oral Exam and the Barrow Oral Care Protocol 
were used to guide oral assessments guide oral care for intensive care unit 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
patients.  
 This study compared the incidence of VAP and the cost of oral care supplies 
before and after implementation. 
 The intervention resulted in a decrease in the incidence of VAP from 4.21 to 2.1 
per 1000 ventilator days (p =.04). Additionally, a cost savings of 65% was noted 
on a monthly basis for oral hygiene supplies and nursing staff reported increased 
satisfaction in providing oral hygiene with a combination of oral care products. 
 The study concluded a significant reduction in the incidence of VAP with the 
Barrow Oral Care Protocol. 
Richards 
(2013) 
Level I  Systematic review and meta-analysis of evidence assessed oral healthcare in 
four domains for the purpose of comparison in the development of VAP. The four 
domains were chlorhexidine (CHX mouth rinse or gel) versus placebo/usual 
care, tooth brushing versus no tooth brushing, powered versus manual tooth 
brushing and comparisons of oral care solutions 
 This systematic review included 35 RCTs (5374 participants) and classified the 
trials according to their risk for bias, quality of evidence, and outcomes 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
associated with a reduction in VAP.  
 Seventeen RCTs (2402 participants) provide moderate quality evidence that oral 
care utilizing CHX mouth rinse or gel, as compared to placebo or usual care is 
associated with a reduction in VAP (OR .60, 95% CI .47 to .77, P < .001, I(2) = 
21%) A number needed to treat (NNT) of 15 (95% CI 10 to 34) was established.  
 There was no evidence of a difference between CHX and placebo/usual care in 
the outcomes of mortality, duration of mechanical ventilation or duration of ICU 
stay.  
 There was insufficient evidence to determine whether there was a difference 
between CHX and placebo/usual care in the outcomes of duration of use of 
systemic antibiotics, oral hygiene indices, microbiological cultures, caregivers' 
preferences or cost.  
 Only three studies reported any adverse effects, and these were mild with similar 
frequency in CHX and control groups.  
 Four RCTs (828 participants) compared oral hygiene without tooth brushing with 
and without CHX, and was no evidence of a difference in the VAP rate (OR .69, 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
95% CI .36 to 1.29, P = .24, I (2) = 64%).  
 This review concluded that effective oral care is important in reducing VAP 
among ventilated patients in intensive care units. Oral healthcare that includes 
either CHX mouthwash or gel is associated with a 40% reduction in the odds of 
developing VAP in critically ill adults. 
Ross et al., 
(2007) 
Level IV  Implementation of an evidence based oral care program that focused on patient 
safety, quality improvement, and improved patient outcomes (VAP reduction).  
 Implementation of an oral health assessment guide.  
 Concluded that an oral health assessment guide decreased median oral 
assessment guide scores (pre-test: eleven, post-test: nine).  
 Analysis (t-test) revealed a statistically significant difference (p= .0002) 
 The frequency of oral care documentation improved. 
Shi et al., 
(2013) 
Level I  Systematic review and meta-analysis of evidence comparing the effects of oral 
hygiene care in the form of mouthwashes, gel rinses, tooth brushing (or in 
combination), and aspiration of secretions on the incidence of VAP among 
critically ill mechanically ventilated patients from 1980 to January 2013. 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
 Thirty-five RCTs (5374 participants) were included in this review and were 
classified according to their risk for bias, quality of evidence, and outcomes 
associated with VAP reduction. 
 There were four main comparisons domains: or care solutions such as CHX 
mouths rinse and CHX gel, versus placebo/usual care, tooth brushing versus no 
tooth brushing, powered versus manual tooth brushing and comparisons of oral 
care solutions such as saline, a weak povidone iodine solution, peroxide solution 
and tap water. 
 There is moderate quality evidence from 17 RCTs (2402 participants) that CHX 
mouth rinse or gel, when compared to usual care was associated with a 
reduction in VAP (OR .60, 95% (CI) .47 to .77, P < .001, I(2) = 21%). This is 
equivalent to a number needed to treat (NNT) of 15 (95% CI 10 to 34) indicating 
that for every 15 ventilated patients in intensive care receiving oral hygiene 
including chlorhexidine, one outcome of VAP will be prevented.  
 There is no evidence of a difference between CHX and placebo or usual care in 
the outcomes of mortality (OR 1.10, 95% CI .87 to 1.38, P = .44, I(2) = 2%, 15 
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Author(s) 
Date 
Levels of 
Evidence 
Key evidence and related findings 
RCTs, moderate quality evidence); duration of mechanical ventilation (MD .09, 
95% CI -.84 to 1.01 days, P = .85, I(2) = 24%, six RCTs, moderate quality 
evidence); or duration of ICU LOS (MD -.21, 95% CI -1.48 to 1.89 days, P = .81, 
I(2) = 9%, six RCTs, moderate quality evidence). 
 One RCT compared use of a mechanical toothbrushing to manual toothbrushing. 
The study provided insufficient evidence to determine the effect of intervention 
on any of the measurable outcomes of this review.  
 A range of other oral care solutions were compared. There was weak evidence 
that povidone iodine mouth rinse is more effective than saline in reducing VAP 
(OR .35, 95% CI .19 to .65, P = .0009, I(2) = 53%) (two studies, 206 participants, 
high risk of bias). However, due to the variation in comparisons and outcomes 
among the trials, there is insufficient evidence concerning the effects of other 
oral care solutions on the outcomes of interest. 
 The authors concluded that the provision of oral hygiene that includes CHX 
mouth rinse is associated with a 40% reduction in the odds of developing VAP 
among critically ill adults residing in the intensive care unit. There was no 
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Author(s) 
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Key evidence and related findings 
evidence of a difference in mortality, duration of mechanical ventilation or 
duration of ICU length of stay. 
 There was weak evidence to suggest that povidone iodine mouthrinse is more 
effective than saline in reducing VAP. There is insufficient evidence to determine 
whether powered toothbrushing or other oral care solutions are more effective in 
reducing VAP when compared to manual brushing with CHX. 
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Figure 2.2  
CONSORT Flow Diagram 
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Theoretical Framework  
 This section will discuss the theoretical framework that was chosen to inform this 
evidence based practice change. A review of literature that represents an integrative review was 
conducted and will be discussed.  
Diffusion of Innovation 
 The theoretical framework chosen for this EBP project is Rogers’ Diffusion of 
Innovations (DOI). This well-established model, with more than 5000 publications associated 
with it since it was first published in 1962, is rooted in the works of Gabriel Tarde, a French 
sociologist, criminologist and social psychologist, who plotted the original S-shaped diffusion 
curve. DOI is of current importance because "most innovations have an S-shaped rate of 
adoption" (Rogers, 1995). Over the past decades, the Diffusion of Innovation paradigm has 
been implemented and validated by scholars from diverse disciplines and fields of study such as 
anthropology, sociology, education, public health, nursing, medicine, communications, and 
marketing, according to Rogers (2003). 
Theory description 
Nursing, like other allied health care fields, is a science-based profession. Research and 
technology continually evolve and it is expected that corresponding care and treatments evolve 
as well (Frantsve-Hawley & Meyer, 2008). New scientifically informed ideas, technologies, and 
methods can be successfully implemented and adopted for a variety of systems through the use 
of Rogers’ Diffusion of Innovations Theory (DOI). This theory fits well with this EBP project 
because it provides a framework though which the adoption and use of innovation can effect 
social change.  
Diffusion of Innovation typically refers to a process by which a system adopts a new 
practice. Rogers defines innovation as an ideal, or practice, that is perceived as new by a 
person, unit, or organization. Diffusion, according to Rogers (2003), is the process by which an 
innovation is communicated through certain channels over time among the members of a social 
PREVENTING VAE 43 
system or organization (Frantsve-Hawley & Meyer, 2008). Rogers’ DOI (1995, 2003) proposes 
that adopters of any new innovation or idea can be categorized based on the number of 
standard deviations from the mean of the normal curve. It also proposes that each system’s 
willingness and ability to adopt an innovation depends on their awareness, interest, evaluation, 
trial, and adoption. Adoption occurs through subjective evaluation and communication regarding 
the new innovation by those who have had success with the innovation (Frantsve-Hawley & 
Meyer, 2008; Rogers, 2003).  
Diffusion occurs through a five–step decision-making process. Rogers' five stages 
include: knowledge, persuasion, decision, implementation, and confirmation. The first step, 
knowledge, is influenced by needs and desires of the decision making unit as well as the prior 
conditions such as traits and norms of the group (Rogers, 2003). Persuasion is determined by 
how adopters will perceive (a) the need for innovation and (b) the characteristics of the new 
practice (Frantsve-Hawley & Meyer, 2008; Simpson, 2011). If the innovation is of relative 
advantage or perceived to be significantly better than current practice, well suited to the goals 
and values of the organization (compatibility), easy to use and understand (simplicity), able to 
be tried out first (trialability), and demonstrably beneficial (observability) then it is more likely to 
be adopted. However, the decision stage takes into account the change and weighs the 
advantages and disadvantages for using the innovation and decides whether to adopt or reject it 
(Rogers, 2003). During the implementation phase, if the innovation is determined to be useful, it 
is put into practice. The last stage is confirmation and it involves the evaluation of outcomes 
related to the innovation and the reaffirmation that the implementation was the right decision.  
 The innovation must be widely adopted in order to be self-sustaining. The rate of 
adoption is variable and is measured by the length of time required for a percentage of 
individuals to adopt the innovation. The rate of adoption has to reach a critical mass, a point at 
which enough persons have adopted the innovation for it to continue. Rogers suggests a 
number of strategies that could be used to achieve the critical mass: (a) have a highly respected 
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individual within a social network adopt and promote the innovation, (b) create a desire for a 
specific innovation, (c) inject an innovation into a group of early adopters who would readily use 
it, and (d) provide positive feedback and benefits for early adopters (Rogers, 2003). 
 Diffusion signifies a group phenomenon, which suggests how an innovation spreads 
through the different adopter categories. The categories of adopters are: innovators, early 
adopters, early majority, late majority and laggards. Among those, there are certain 
characteristics of early adopters that should be noted. Rogers describes early adopters as 
having a higher social status, being more financially stable, well-educated, and more socially 
forward than late adopters (Rogers, 2003). Opinion leaders, Rogers suggest, derive 
predominately from the early adopter category and exert influence over the others. Opinion 
leaders are influential in spreading either positive or negative information about an innovation. 
They have greater exposure to the mass media, are in contact with change agents, have a 
higher social experience, better socioeconomic status, and are more personally innovative than 
others (Rogers, 2003).  
 There are consequences to innovation. Both positive and negative outcomes are 
possible when an individual or organization chooses to adopt or reject a particular innovation. 
Rogers lists three categories for consequences: desirable or undesirable, direct or indirect, and 
anticipated or unanticipated. The benefits of an innovation are the positive consequences, while 
the costs are the negative. Costs may be direct or indirect. Direct costs are usually related to 
financial burden while indirect costs are more difficult to identify. An example would be the need 
to ‘staff up’ in order to implement an innovative change. Indirect costs may also be social, such 
as social conflict caused by innovation (Rogers, 2003; Simpson, 2011). 
Theoretical Framework Strengths and Limitations 
 The strengths of using Rogers’ DOI framework for this EBP project are readily apparent. 
The DOI model continues to be applied successfully to different specialties with varying 
problems and needs. The areas of application for these studies range from agriculture, 
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engineering, mathematics, and nursing (Rogers, 1995; Simpson, 2011). This is largely due to 
the model’s generalizability and transferability to applied research (Greenhalgh, Robert, 
Macfarlane, Bate & Kyriakidou, 2004; Rogers, 2003). 
Limitations of Rogers’ DOI framework include pro-innovation bias and individual-blame 
bias (Rogers, 2003). Pro-innovation bias is the belief that an innovation should be adopted by a 
system without the need of its alteration. The innovation's change agent has such strong bias in 
favor of the innovation, that limitations remain inadvertently unnoticed.  A second limitation is 
individual-blame bias. The individual-blame bias is a tendency to blame individuals for their non-
adoption. Some persons are laggards simply because they do not like change and are slow to 
adapt to change. The responsible change agent must look beyond such individualistic 
explanations to fully understand the rationale for systematic non-adoption. Instead, the change 
agent should examine how the characteristics of the innovation might influence human behavior 
toward adoption or rejection of a change effort.  
Application of the Theoretical Framework to EBP Project 
Everett Rogers’ ground-breaking framework has contributed to a greater understanding 
of innovative change, including the variation in rates of adoption of innovations, and it has held a 
broad scope of practical applications in the nursing and dental fields. Principles from the Rogers 
theoretical framework are incorporated into this EBP project. Key concepts of the framework are 
italicized in this section to highlight their application to the EBP project.  
The innovation for this project is a standardized oral health assessment for orally 
intubated patients in the ICU, which is an innovation for the project sites since they have 
historically lacked a standardized oral health assessment. Two oral health assessment tools, 
the modified Beck Oral Assessment Scale (BOAS; Appendix A) and the Mucosa-Plaque Score 
(MPS; Appendix B) will be combined to form one standardized oral health assessment tool 
specific for patients with endotracheal tubes. These tools have been shown to identify early 
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evidence of oral biofilm development, which is an important early step in the development of 
VAC.  
 Gaining approval and support of opinion leaders is an essential step in Rogers’ model.  
The opinion leaders for this project initially consisted of the unit manager and unit clinical nurse 
specialist (CNS) at one of the project sites, who embraced this project from the beginning. 
During the project planning stage, clinical directors, infection preventionists, unit managers, and 
CNS at all participating hospitals were contacted via email over a period of two months in order 
to acquire their support, answer their questions, and discuss any concerns regarding the 
benefits and value of the innovation for patient safety, cost reductions, and process 
improvement. Rogers’ five steps of innovation diffusion are instrumental during these 
discussions. Careful attention to knowledge building and persuasion is necessary throughout 
project implementation and evaluation as adopters use the innovation alongside the myriad 
distractions that are prevalent in the clinical setting. Anticipating these challenges, particularly 
related to the ongoing need for persuasion, is essential for adoption. As advocates for patient 
autonomy, clinicians need validation that the innovation fits within the contract for ethical 
treatment of human research participants. As employees who report to hospital administrators, 
clinicians need validation that their supervisors support the innovation, as well as the overall 
project.  
Clinicians and administrators alike must make the decision to adopt the innovation. For 
administrators, this decision is made when providing the initial approval of the project for use in 
the clinical department and each time they encounter difficulties in sustaining the innovation. 
Clinicians make the decision to adopt the innovation initially when they are given the directive to 
do so (either through education or institutional policy) and each time they are responsible for 
acting on the innovation. Supporting the decision to adopt an innovation requires ongoing 
education and persuasion, which can be accomplished through frequent interactions with 
clinicians and administrators. 
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Implementation of the innovation occurs as the adopter folds the innovation into their 
usual patterns of care. In this project, implementation occurred when the ICU nurses became 
more comfortable using the standardized oral health assessment scale using the correct 
technique and at the correct frequency. This step requires active commitment from the 
adopters, frequent contact with the project leader, and ongoing support from administrators. 
Implementation can be measured through process measures, such as staff compliance with the 
innovation. A downward trend in compliance may indicate the need for more knowledge about 
the innovation, additional persuasion, and reaffirming the decision to continue implementation. 
During the confirmation stage, the adopters are able to sustain the innovation with 
decreasing levels of external support from the project leader or institutional supervisors. 
Process indicators, such as innovation compliance, as well as outcome indicators, such as the 
incidence rate of VAE, can be measured, statistically analyzed, and interpreted for significant 
changes during this stage.  
Strengths and Limitations of Rogers’ Framework in the context of the EBP project 
The strengths of using Rogers’ DOI model for this EBP project are apparent. The DOI 
model continues to be applied successfully to different specialties with varying problems and 
needs. The areas of application for these studies range from agriculture (hybrid seed corn), 
technology (modern math and engineering), and health care (antibiotic use, HIV/AIDS 
prevention, oral health promotion) [Rogers, 1995; Simpson, 2011]. This is largely due to the 
model’s generalizability and transferability to applied research (Greenhalgh, Robert, Macfarlane, 
Bate & Kyriakidou, 2004; Rogers, 2003).  
Everett Roger's DOI framework has contributed to a greater understanding of behavioral 
change, including the variation in rates of adoption of innovations, and it has held a broad scope 
of practical applications in the healthcare field. However, the investigator anticipated two major 
limitations of the diffusion approach in the context of this EBP project. The first such limitation 
was pro-innovation bias or the belief that everyone should unequivocally adopt the innovation as 
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it exists. The investigator, as change agent, planned to mitigate pro-innovation bias by inviting 
stakeholders to participate in giving feedback on the proposed innovation. This systematic 
approach gave stakeholders an opportunity to voice their concerns and to understand how the 
innovations would impact their workflow. A second anticipated limitation was individual-blame 
bias or the tendency to blame individuals for their non-adoption. The investigator planned to 
mitigate this bias by investigating how the characteristics of the innovation might affect laggards 
or those resistant to change. The study not only included in-services for all staff nurses at the 
four facilities regarding the rationale for and use of the innovation, but also reinforced the 
change effort by rounding on a bi-weekly basis. Within this EBP project, the investigator planned 
to mitigate potential limiting factors by inviting all stakeholders to explore the benefits and 
consequences of adopting a new approach.  With the inclusion of these planned mitigation 
efforts, the DOI provided a framework that fit well with this EBP project. 
The evidence suggests that the incidence of the various conditions that comprise VAE 
can be reduced through the use of interventions that address the agent, host and environmental 
characteristics of disease. A guiding framework is required in order to enhance the likelihood of 
successful implementation and evaluation. The diffusion of innovation framework has attributes 
that make it useful in guiding the selection and implementation of interventions to prevent 
ventilator associated events among mechanically ventilated adults within the critical care 
setting. 
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CHAPTER 3 
METHOD 
 The purpose of this project was to determine if an evidence-based standardized 
oral health assessment, combined with a staff education program, would reduce the 
incidence of ventilator associated events (VAE) among mechanically ventilated adults 
admitted into the intensive care units at four Midwest community hospitals. The review of 
literature supported a multifaceted intervention including routine structured oral 
assessments and staff education to improve oral care techniques. This chapter 
describes the population of interest, setting, and methods used for outcomes 
measurement, data analysis, as well as the procedures for implementation of the 
Evidence-Based Practice (EBP) project. Data management and protection of human 
subjects is also addressed.   
Participants and Setting 
The sites for this EBP project were four community hospitals in the Midwest, 
which are part of a multi-hospital not-for-profit organization. The settings of 
implementation include four medical-surgical intensive care units at these facilities and 
these units served as the units of analysis. These ICU areas admit critically ill patients at 
least 18 years of age, and approximately one-half receive mechanical ventilation via 
endotracheal tube. Because intervention and outcome data were not collected at the 
patient-level, demographic variables were not measured. However, ventilator-days 
(defined as the number of patients receiving mechanical ventilation at midnight census) 
during the study period were collected from an administrative database.  
Design and Outcome Variables  
This EBP project utilized a single-group pretest-posttest design in which all 
project sites began using the intervention simultaneously. The monthly VAE incidence 
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rate on each ICU was reported for a total of 13 months (nine months before 
implementation, four months after implementation). Standardized surveillance definitions 
for VAE were utilized for measurement of VAE incidence (Table 3.1). Briefly, incidence 
was calculated as the number of VAE cases per unit per month divided by the number of 
ventilator-days per unit per month, then standardized to a scale of 1,000 ventilator-days 
(# cases / # ventilator-days * 1,000 ventilator-days), which is consistent with the scale 
used in VAP prevention literature. The infection preventionist at each study site provided 
aggregated data at the unit level for the outcome variables listed in Figure 3.1.  
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Table 3.1 
Outcome variables: National Healthcare Safety Network (NHSN) surveillance definitions 
Variable Operational Definition 
Time Defined in calendar months pre and post- implementation. 
Patient-Days Number of patients reported on the midnight census each day. 
Ventilator-Days Number of patients on a ventilator reported on the midnight census each day. 
Ventilator Device A device to assist or control respiration, inclusive of the weaning period, through a tracheostomy 
or by endotracheal intubation. 
Ventilator Device 
Utilization Rate 
 
Ventilator Device Utilization Ratio measures the proportion of total patient-days in which 
ventilators were used on a given unit during a specified time period. It is calculated by dividing the 
number of ventilator days by the number of patient days. 
VAE Count Number of VAE cases of patients on invasive mechanical ventilation; utilized standardized 
surveillance definitions for VAE  
VAE Rate 
 
Total number of ventilator-associated events derived from a specific standard population during a 
specified time period. 
VAC Rate Total number of observed healthcare-associated VACs among critically ill adult patients in the ICU 
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Variable Operational Definition 
IVAC Rate 
 
Total number of observed healthcare-associated IVACs among critically ill adult patients in the 
ICU 
Possible and 
Probable VAP 
rate 
Total number of observed possible and probable VAP cases (with manifestations of purulent 
respiratory secretions or positive respiratory cultures) among critically ill adult patients in the ICU. 
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Intervention 
Staff members that received the educational intervention were unit-based or float pool 
staff registered nurses (RN) assigned to work in one of the study settings. The intervention had 
two main components: (a) a standardized oral assessment and (b) an educational in-service for 
staff registered nurses at the study units that focused on the objectives listed in Table 3.3. 
Implementation of the intervention occurred at all sites over a 1-month period of time (October 
2014), after which, post-intervention outcomes data collection commenced on a pre-determined 
date at all sites.  
The standardized oral assessment was comprised of two non-invasive oral assessment 
tools: the Beck Oral Assessment Scale (BOAS) (Table 3.1) and the Mucosa-Plaque Score 
(MPS) (Table 3.2). As described in Chapter 2 of this EBP report, both of these tools have good 
internal consistency when used together. The BOAS and the MPS were incorporated into a 
standardized oral assessment data collection form (Figure 3.0) to increase the accuracy of the 
measured variables.  
Additionally, the combined tool has excellent internal consistency as evidenced of a 
Cronbach’s alpha of greater than .7.  
The standardized oral assessment was to be performed every shift (defined for this 
project as every 12 hours). All nurses received the same educational content, and time was 
provided at the end of the in-service to answer questions.  
PREVENTING VAE 54 
Table 3.2  
Beck Oral Assessment Scale (BOAS), modified 
  Score   
 1 2 3 4 
Lips Smooth, pink, 
moist, 
and intact 
Slightly dry, 
red 
Dry, swollen 
isolated 
blisters 
Edematous, 
inflamed 
blisters 
Gingiva and 
oral mucosa 
Smooth, pink, 
moist, 
and intact 
Pale, dry, 
isolated 
lesions 
Swollen red Edematous, 
inflamed 
blisters 
Tongue Smooth, pink, 
moist, 
and intact 
Dry, 
prominent 
papillae 
Dry, swollen, 
tip and 
papillae are 
red 
with lesions 
Very dry, 
edematous, 
engorged 
coating 
Teeth Clean, no 
debris 
Minimal debris Moderate 
debris 
Covered with 
debris 
Saliva Thin, watery 
plentiful 
Increase in 
amount 
Scanty and 
somewhat 
thicker 
Thick and 
ropy, viscid 
or mucid 
Total Score 5 
No dysfunction 
6-10 
Mild dysfunction 
11-15 
Moderate 
dysfunction 
16-20 
Severe 
dysfunction 
Intervention 
Frequency 
Minimum care 
every 12 h 
Minimum care 
every  
8-12 h 
Minimum care 
every 8 h 
Minimum care 
every 4 h 
Note: Modified from Beck, S. (1979). Impact of a systematic oral care protocol  
on stomatitis after chemotherapy. Caner Nursing, 2, 185-199. 
Reprinted with permission from the Lippincott Williams & Wilkins,  
International Society of Nurses in Cancer Care and the European Oncology  
Nursing Society. Copyright Clearance Center Confirmation Number: 11266253
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Table 3.3 
Mucosa-Plaque Score (MPS) 
Criteria 
Mucosa 
Normal appearance of gingiva and oral 
mucosa………………………………………………………………………..……………….1 
Mild inflammation = slight redness and or hypertrophy/hyperplasia 
Slight redness in some areas of the palatal mucosa; red spots indicating inflamed 
salivary duct 
orifices………………………………………………………………………………………….2 
Moderate inflammation = marked redness and hypertrophy/hyperplasia of the gingiva, 
which bleeds easily when pressure is applied and/or any of the following:  
 Marked redness in large areas (≥2/3) of palate 
 Marked inflammatory redness of the oral mucosa in sites other than the palate 
 Presence of ulcerations 
 Red and inflamed fibroepithelial hyperplasia …..…………………………………3 
Severe inflammation = severe redness and hypertrophy/hyperplasia of the gingiva 
 Spontaneous gingival bleeding 
 Marked palatal granulations 
 Inflamed oral mucosal areas that “break” easily and bleed under 
pressure…...............................................................................................………4 
Plaque 
No easily visible plaque 
……………………………………………………………………………………….……….…1 
Small amounts of hardly visible 
plaque……………………………………………………………………………….………….2 
Moderate amounts of 
plaque……………………………………………………………………………….………….3 
Abundant amounts of confluent 
plaque…………………………………………………………………………….…………….4 
Score Greater than 5 reflects marked lack or oral integrity 
Note: Based on data in Henriksen, B. M., Ambjornsen, E., & Axell, T. E. (1999). Evaluation of a 
mucosal-plaque index (MPS) designed to assess oral care in groups of elderly. Special Care in 
Dentistry, 19, 154-157.  Silness, P., & Löe, H. (1964). Periodontal disease in pregnancy, II: 
Correlation between oral hygiene and periodontal condition. Acta Odontologica Scandinavica, 
22(1), 121-135.  Reprinted with permission from the American Dental Association; American 
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PREVENTING VAE 56 
Figure 3.1 Oral Health Assessment Tool 
 
ORAL HEALTH ASSESSMENT TOOL 
FOR MECHANICALLY VENTILATED ADULTS IN ICU 
 
BECK ORAL ASSESSMENT SCALE  (BOAS) 
Date:        
Shift 
N=11p-7a; D=7a-3p; E=3p-11p 
N D E N D E N D E N D E N D E N D E N D E 
Lips                      
Gingiva/Mucosa                      
Tongue                      
Teeth                      
Saliva                      
Total  
Score 
                     
 
 BOAS Score Legend 
1 2 3 4 
Lips Smooth, pink, moist, intact Slightly dry, red Dry, swollen isolated blisters Edematous, inflamed blisters 
Gingiva & Oral 
Mucosa 
Smooth, pink, moist, intact Pale, dry, isolated 
lesions 
Swollen, red Edematous, inflamed blisters 
Tongue Smooth, pink, moist, intact Dry, prominent 
papillae 
Dry, swollen, tip and papillae are 
red with lesions 
Very dry, edematous, engorged 
coating 
Teeth Clean, no debris Minimal debris Moderate debris Covered with debris 
Saliva Thin, watery, plentiful Increase in amount Scanty and somewhat thicker Thick and ropy, viscid or mucid 
Total Score: 
Dysfunction 
5: None 6-10: Mild  11-15: Moderate 16-20: Severe 
Intervention 
Frequency 
>= Every 12 h >= Every 8-12 h >= Every 8 h >= Every 4 h 
 
 
MUCOSAL-PLAQUE SCORE (MPS) 
Date:        
Shift 
N=11p-7a; D=7a-3p; E=3p-11p 
N D E N D E N D E N D E N D E N D E N D E 
Mucosa                      
Plaque                      
Total  
Score 
                     
 
 
 MPS Score Legend 
1 2 3 4 
Mucosa Normal appearance of 
gingiva and oral mucosa 
Mild inflammation: slight 
redness and or 
hypertrophy/hyperplasia. 
Slight redness in some 
areas of the palatal 
mucosa; red spots 
indicating inflamed salivary 
duct orifices 
 
Moderate inflammation: marked 
redness and hypertrophy/hyperplasia 
of the gingiva, which bleeds easily 
when pressure is applied and/or any 
of the following:  
 Marked redness in large areas 
(≥2/3) of palate 
 Marked inflammatory redness 
of the oral mucosa in sites 
other than the palate 
 Presence of ulcerations 
 Red and inflamed 
fibroepithelial hyperplasia 
Severe inflammation: 
severe redness and 
hypertrophy/ hyperplasia of 
the gingiva:  
 Spontaneous gingival 
bleeding 
 Marked palatal 
granulations 
 Inflamed oral mucosal 
areas that “break” 
easily and bleed 
under pressure 
Plaque No easily visible plaque Small amounts of hardly 
visible plaque 
Moderate amounts of plaque Abundant amounts of 
confluent plaque 
Interpretation A total score greater than 5 reflects a significant lack of oral integrity. 
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Implementation Plan 
Everett Rogers’ DOI framework served as a useful map for planning this EBP project. 
Table 3.3 provides detailed descriptions of how each of these stages influenced innovation 
adoption in this EBP project.  
Knowledge of the local problem with VAE had already been established by the clinical 
directors, unit managers, IP, and CNS, but there was a knowledge gap regarding the solution to 
this problem. Therefore, the first step in this project was to explore with the clinical stakeholders 
what the barriers were to achieving their goal of having no VAE in their facilities. One such 
barrier was a lack of standardized oral health assessment practices, and another was poor 
compliance to evidence-based procedures for oral care of patients with mechanical ventilation. 
While the clinical stakeholders perceived both of these barriers to be important, they agreed that 
the emphasis for this project was to develop, implement, and evaluate a standardized oral 
health assessment procedure. Clinical stakeholders decided to facilitate this project with the 
expectation that any staff education would also include a review of the approved standards of 
care for oral hygiene.  
After agreeing to the project aims, timeline, and responsibilities of the clinical sites and 
EBP project leader, the project was planned with substantial input from the clinical stakeholders 
and the EBP project advisor. After achieving consensus on project methods, approval to 
conduct human subjects research was obtained from the institutional review board (IRB) at both 
the academic institution at which the EBP project leader was enrolled as a student and at the 
clinical sites. Obtaining these approvals before approaching clinical staff about the project was 
vital to the successful adoption of the project because it demonstrated to the clinical staff a 
commitment to protect the autonomy of each ICU patient, even though they were not 
individually required to provide informed consent to participate in the project. A plan was also 
developed to establish on-site and on-call availability of the project leader throughout the 
decision and implementation phases.  
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The EBP project leader arranged times at each site to deliver intervention training to the 
nursing staff. Upon completion of the program, nursing staff were expected to: (a) explain the 
significance of oral health assessment in patients with mechanical ventilation, (b) perform a 
standardized oral health assessment for patients with mechanical ventilation, and (c) perform 
site-approved oral hygiene for patients with mechanical ventilation. The educational program 
consisted of a brief oral presentation during a regularly scheduled unit staff meeting, a handout 
that provided further details about the intervention, a project binder with additional information 
about VAE prevention, a one-page flyer that explained how to complete the standardized oral 
health assessment procedure, and a printed poster describing various VAE prevention 
strategies.  
Unit-based leaders at each project site, including nurse managers, charge nurses, and 
clinical nurse specialists, were recruited as change champions to facilitate and motivate staff 
nurses to utilize the standardized oral health assessment tools. These unit leaders also 
implemented “train-the-trainer” sessions at each project site. The nurse manager and CNS at 
each facility identified a site-specific plan to distribute data collection forms, display the 
educational poster, and store completed data collection forms until they could be retrieved for 
data entry. Staff training occurred from October 1st, 2014 through October 31st, 2014. The unit 
leaders, IP, and clinical nursing director agreed to implement the project on November 2nd, 
2014.  
Oral assessment methodology 
Nurses will receive initial training on the use of the oral assessment tools during a unit-
based educational session. Although routine oral care was being performed on mechanically 
ventilated patients, staff had not consistently assessed for evidence of biofilm growth within the 
mouth of mechanically ventilated patients. The innovation was conceptually embraced by the 
nurse manager, the regional education manager, and the regional chief nursing officer (CNO). 
The investigator proposed an in-service in which she would discuss each facility's VAE/VAC 
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prevention protocol with the addition of teaching nurses a systematic way to assess the 
intubated patient's oral health status. The initiative was implemented at four Midwestern 
hospitals.  
On, November 2nd, 2014, follow-up phone calls, reiterating the importance of the EBP 
project, were made to unit managers, unit team leaders, or charge nurses as a reminder of the 
implementation date on the following day. The EBP project leader began bi-weekly site visits to 
reinforce or provide additional training, as needed, to promote intervention adherence among 
unit staff. These site visits were performed on all shifts for several weeks and then were 
performed exclusively on the day (7:00 A.M. to 7:00 P.M.) shift to ensure availability to the nurse 
managers and CNS, who primarily worked on this shift. The decision to change the schedule for 
site visits was made based on feedback from the nurse manager and CNS at these sites.  
During the implementation of the study, when the patient arrived to the critical or 
intermediate care areas, the staff nurses assessed the oropharyngeal and mucus membranes, 
teeth, and artificial airway for risk factors and signs and symptoms of deterioration or infection. 
The BOAS and MPS were quantified either upon patient intubation or arrival to the critical care 
unit, whichever came first. Patients at low risk for developing VAE received preventive 
measures, including mechanical tooth brushing and chlorhexidine application at least every 12 
hours. Those patients who were revealed to have mild to severe oropharyngeal and mucus 
membrane dysfunction had mechanical oral care more frequently, per institutional policy. 
Additionally, primary care providers were instructed regarding the potential severity of the of 
oropharyngeal and mucus membrane dysfunction in order to facilitate a more collaborative 
treatment approach for critically ill patients at high risk for VAE development.
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Table 3.4 
Application of Rogers Diffusion of Innovation 
Rogers Stage of Change EBP Project Action Step 
Acquisition of Knowledge  Change in NHSN surveillance definitions of VAE/VAC/VAP 
 Study site acknowledgement of inconsistent oral care in patients with 
endotracheal tubes 
 Email sent to regional director of critical care and infection prevention at study 
setting explaining the proposed EBP project focusing on prevention of VAP 
 Meeting with site leaders to explain the project purpose, scope, and proposed 
methods 
Persuasion  Obtained strong support of leaders at study sites 
 Identified change champions at each study site 
Decision-Making  Administration authorized the practice change at all study sites 
 Change champions were educated on the study purpose and methods 
 Feedback sought from change champions for ways to maximize study 
procedure adherence among staff 
Implementation  EBP project leader attended departmental staff meetings to explain the study 
purpose, how to perform the standardized oral assessment, reinforcement of 
facility VAP prevention protocol, and how to submit the completed oral 
assessment tool to the EBP project leader 
 Bi-weekly project leader site visits to support implementation 
 Meetings with site leaders and change champions as needed to clarify project 
goals and methods 
Confirmation  Standardized oral assessment will be included in the next revision of regional 
VAP prevention protocol 
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Data Analysis Plan 
Ventilator-associated events were counted each month at all project sites and 
standardized across sites using ventilator-days. The incidence rate of VAE per month was 
calculated for each site, along with the incidence rate of all VAE subtypes (i.e. VAC, IVAC, 
possible VAP, and probable VAP). To test the null hypothesis that there was no statistically 
significant difference between VAE incidence from pre-intervention to post-intervention, a 2x2 
contingency table was constructed for each site using data from all four project sites with VAE 
(present or absent) on one axis and implementation phase (pre-implementation or post-
implementation) on the other axis. From this table, a chi-square test of independence was 
performed and a p-value calculated using α = .05 as the level of significance. A pooled VAE 
incidence rate for all sites, which accounted for variations in ventilator-days between sites, was 
also calculated for pre-intervention to post-intervention, and the process for hypothesis testing 
repeated as it was performed for each individual site.  
To analyze the second aim, staff compliance with the standardized oral assessment was 
determined by utilizing the oral assessment form as a proxy for compliance. To determine the 
strength of the association between staff compliance with the intervention and the change in 
VAE incidence rate from pre-intervention to post-intervention, a Spearman’s ρ correlation 
coefficient and a p-value calculated using α = .05 as the level of significance. Data were 
analyzed using IBM’s Statistical Package for the Social Sciences (SPSS) software (SPSS, 
2015).
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Table 3.5   
Data Analysis Plan   
Question to be Answered Measures Statistical Test 
Did the incidence rate of VAE 
decrease after implementation 
of a standardized oral 
assessment for adult patients on 
mechanical ventilation? 
VAE incidence rate 
 
VAC incidence rate 
 
IVAC incidence rate 
 
PossVAP incidence rate 
 
PrVAP incidence rate 
Chi-square test for independence 
Was compliance with the 
standardized oral assessment 
associated with the incidence 
rate of VAE in this population?  
 
Incidence rates at each site, as 
above 
 
% of vent-days with at least two 
completed oral assessments on 
data collection form 
Spearman’s ρ  
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Human Subjects Protection 
 Institutional Review Board (IRB) approval was obtained from both the study site and 
Valparaiso University prior to project implementation. Because this project utilized aggregated 
system-level data instead of individual patient-level data, the project did not require the 
acquisition of informed consent from individuals. Furthermore, since there was minimal risk 
beyond that involved with receiving routine clinical care, and the informed consent document 
would have been the only way to identify individual participants, this project was granted 
“exempt” status from both IRBs. Facility infection preventionists, who served as the sources for 
data on study outcomes, de-identified and aggregated outcomes data at the unit level prior to 
these data being sent to the EBP project leader. All outcomes data were sent electronically 
directly from the infection preventionist to the PI via e-mail communication. Each study site 
assigned a specific place for staff nurses to submit the standardized oral assessment data 
collection forms, which were kept in an opaque envelope or folder. The PI collected these forms 
bi-weekly and transported them to a locked filing cabinet using a closeable binder.  
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CHAPTER 4 
FINDINGS 
The purpose of this EBP project was to determine if an evidence-based oral care 
assessment combined a with staff education program reduced the incidence of ventilator 
associated events (VAE) among mechanically ventilated (whether via oral endotracheal 
intubation, nasal endotracheal intubation, or tracheostomy) adults admitted into the intensive 
care units at four Midwestern community hospitals over a four-month period, compared to 
routine oral care practices over a prior nine-month period. This chapter will provide results from 
the data analyses of the study.  
In order to determine the effectiveness of the EBP project protocol, pre-intervention and 
post-intervention VAE incidence rates and facility EBP protocol documentation compliance were 
monitored on a monthly basis. Analyses of all variables are listed on Tables 4.1, 4.2, 4.3 and 
4.4. The data from all four participating facilities were then pooled for the purpose of statistical 
analysis using SPSS version 22 software.  
Patient-Days and Ventilator-Days 
This project utilized an administrative data set that included patient-days and ventilator-
days at each facility. Pre and post-intervention data were collected over a pre-determined date 
range at all participating sites. The pre-intervention period began January 1, 2014 and ended on 
September 30, 2014. A one-month implementation phase was scheduled during October 2014. 
Post-intervention data collection began on November 1, 2014 and continued until February 28, 
2015. 
Patient-days were calculated as the total number of patients in each intensive care unit 
at midnight every day over each one-month period. Ventilator-days were calculated as the total 
number of patients using mechanical ventilation in each intensive care unit at midnight every 
day over each one-month period.  
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Patient-days.  A total of 13,050 patient-days were examined in this study (9,149 pre-
intervention patient-days; 3,892 post-intervention patient-days). Table 4.1 provides details of the 
distribution of patient-days at the 4 facilities.  
Ventilator-days. Of the 13,050 patient-days, there were 4,892 ventilator-days (3,304 
pre-intervention ventilator-days; 1,588 post-intervention ventilator-days). Table 4.1 provides 
details of the distribution of ventilator-days at the 4 facilities.  
Staff Compliance with Evidence-Based Practice 
Daily completion of the Oral Health Assessment Tool was used as an indicator of staff 
compliance with the standardized oral health assessment practice. Staff compliance was 
calculated as the percentage of ventilator-days during the post-implementation phase with at 
least two documented oral health assessments per day. Of 1,588 ventilator-days in the post-
implementation phase, 399 had at least two documented oral health assessments (25.1%). The 
staff compliance between facilities ranged from 2% to 70% (Table 4.2).  
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Table 4.1 
Patient-days and ventilator-days at study facilities 
Facility Patient-Days (%) Ventilator-Days (%) 
 Pre-Implementation Post-Implementation Total Pre-Implementation Post-Implementation Total 
A 2356 (26) 824 (21) 3180 694 (21) 275 (17) 969 
B 2166 (24) 1065 (27) 3231 582 (17) 343 (22) 925 
C 1848 (20) 741 (19) 2589 650 (20) 271 (17) 921 
D 2779 (30) 1271 (33) 4050 1378 (42) 699 (44) 2077 
Pooled 9149 (100) 3901 (100) 13050 3304 (100) 1588 (100) 4892 
Note: Administrative data set.  
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Table 4.2 
Staff compliance with evidence-based oral health assessment protocol 
Facility Correct Documentation Ventilator-Days Staff Compliance % 
A 28 275 10.2 
B 240 343 70 
C 6 271 2.2 
D 125 699 17.9 
Total 399 1588 25.1 
Criteria: At least two documented oral health assessments per day.  
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Instrument Reliability 
Two standardized, non-invasive, oral assessment tools (i.e., the Beck Oral Assessment 
Scale [BOAS] and the Mucosa-Plaque Score [MPS]) were combined for this EBP into the Oral 
Health Assessment Tool (Figure 1). Although the need to evaluate the psychometric properties 
of the BOAS and the MPS have been discussed elsewhere (Beck, 1979; Henriksen, 
Ambjornsen, & Axell, 1999; Silness, & Löe, 1964), no published results were found in the 
literature search. Inter-rater reliability coefficients for the BOAS, MPS, and the Oral Health 
Assessment Tool were calculated for the sample in this EBP project as .742, .592, and .824, 
respectively (Table 4.3). This demonstrated that the reliability of the instrument combining the 
MPS and BOAS was greater than the use of either scale alone. Validity of these scales was not 
calculated as part of this EBP project. 
Table 4.3 
Internal consistency of instruments 
Instrument Number of Items Cronbach’s α 
Beck Oral Assessment Scale (BOAS) 5 .742 
Mucosa-Plaque Score (MPS) 2 .592 
Oral Health Assessment Tool 7 .824 
 
Outcome Variables 
VAE Incidence Rates. The PICOT question guiding this analysis asked, “Among 
mechanically ventilated patients, how does the implementation of a standardized oral care 
assessment guideline combined with a mandatory staff education program affect the incidence 
of VAE when compared to standard care over a four month period?” VAE incidence rates varied 
at all participating facilities (Table 4.4). However, during the pre-implementation phase, VAE 
incidence rates at three participating facilities were less than 8.7 per 1,000 ventilator days. 
Facility A exceeded that rate at 17.3 per 1,000 ventilator days. For comparison purposes, the 
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pooled VAE rate for all sites was calculated. During the pre-implementation phase, the pooled 
mean incidence rate for VAE across the four facilities was 9.99 per 1,000 ventilator-days (Table 
4.4). During the post-implementation phase, VAE incidence rates continued to vary among the 
four facilities (Table 4.4). The pooled mean incidence rate of VAE at all sites decreased to 8.2 
per 1,000 ventilator-days in the post-implementation phase. However, this change was not 
statistically significant. 
Ventilator-associated pneumonia (VAP) was a relatively rare type of VAE in this sample, 
which is consistent with the literature (CDC, 2014). There were no cases of confirmed VAP 
during either the pre-implementation or the post-implementation phase. There were only four 
cases of probable VAP during pre-implementation (all occurring at the same facility) and no 
cases of probable VAP during post-implementation. Because the incidence of confirmed and 
probable VAP was extremely low, statistical analysis of the VAP outcome variable was not 
performed.  
Figure 4.1 
Pre and Post Changes in VAE Rates 
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Table 4.4  
Changes in VAE incidence rates  
Facility Pre-Implementation Post-Implementation  
Change  
in VAE 
Incidence 
rate 
 
VAE 
Frequency 
(%) 
Ventilator-
Days (%) 
VAE Incidence 
(per 1,000 
ventilator-
days) 
VAE 
Frequency 
(%) 
Ventilator
-Days 
(%) 
VAE Incidence 
(per 1,000 
ventilator-
days) 
p-value 
A 12 (36) 694 (21) 17.3 6 (46) 275 (17) 21.8 4.5 .73 
B 4 (12) 582 (17) 6.9 2 (15) 343 (22) 5.8 -1.1 .85 
C 5 (15) 650 (20) 7.7 1 (8) 271 (17) 3.7 -4 .49 
D 12 (36) 1378 (42) 8.7 4 (31) 699 (44) 5.7 -3 .46 
Inter-facility 33 (100) 3304(100) 9.99 13 (100) 1588(10) 8.2 -1.8 .54 
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Significance of facility-specific VAE incidence rate changes. Changes in VAE 
incidence rate were also analyzed within each facility (Table 4.4). Although reductions in VAE 
incidence were observed at three of these facilities, and an increase in VAE incidence was 
observed at one facility, these differences were not statistically significant.  
Compliance with EBP intervention and post-implementation VAE incidence rate. A 
post hoc analysis that determined the relationship between compliance with documentation of 
the evidence-based oral health assessment protocol and changes in VAE incidence was 
performed. Spearman’s rank correlation coefficient was calculated to assess this relationship. 
Staff compliance with the oral health assessment protocol was positively correlated, but this 
relationship was not statistically significant (r = .4, n = 4, p > .1).  
Table 4.5  
Significance of change in VAE rate and compliance rate, by facility 
Facility Staff Compliance rate %  
(X Value) 
Change in VAE Incidence 
Rate (Y Value) 
A 10.2 4.5 
B 70 -1.1 
C 2.2 -4 
D 17.9 -3 
Inter-facility  25.1 -1.8 
 
The overall pooled results across all four study sites showed a moderate but observable 
decrease in VAE incidence rate from the pre-intervention period to the post-intervention period. 
This result was apparent in the site-specific results at all but one study location, Site A, where 
the incidence rate increased. Notably, despite having had by far the highest compliance with 
study documentation, Site B had the second least favorable change in VAE rate. This suggests 
that any correlation between documentation compliance and the outcome of the intervention 
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was weak. It may be instructive, in subsequent research, to investigate the relationship between 
compliance and individual patient outcomes.  
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Chapter 5 
Discussion 
The purpose of this EBP project was to answer the PICOT question: Among 
mechanically ventilated patients, how does the implementation of an oral care assessment 
guideline when combined with a staff education program, affect the incidence of ventilator-
associated events when compared to standard care over a four month period? This chapter will 
discuss the findings presented in Chapter 4. This chapter will also discuss essential elements of 
the Epidemiological Triangle of Infectious Disease and Everett Rogers’ Diffusion of Innovation 
(DOI) framework (Rogers, 2005) that were used to integrate an evidence-based strategy to 
decrease VAE rates among mechanically ventilated adults in the ICU setting. The applicability 
and fit of the theoretical and EBP framework, strengths and weakness of the EBP projected and 
implications for the future will also be addressed.   
Explanation of Findings 
It was important to determine the clinical feasibility and effectiveness of this EBP 
project’s protocol. Therefore, descriptive statistics were used to assess facility specific, as well 
as organizational pooled mean VAE rates and protocol adherence rates. The statistical software 
SPSS version 22 was used was used to assess ordinal variables by utilizing the Chi Square test 
to measure the strength of association between pre- implementation VAE rate and the post-
implementation VAE rate. 
This single-group pretest-posttest study utilized aggregate data that was collected in 
accordance with NHSN guidelines by facility specific infection preventionist at four community 
hospitals in the Midwest. De-identified data was reported to the principal investigator for 
statistical analysis. The variables included: (a) patient days; (b) VAE count; (c) ventilator days; 
(d) VAE rate; (e) ventilator device utilization (DU); (f) Ventilator-Associated Condition count 
(VAC); (g) Infection-related Ventilator-Associated Complication (IVAC) count; and (h) 
Possible/Probable ventilator associated pneumonia (P-VAP) count.  
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Pre-implementation VAE data for this project were collected using a retrospective 
approach by facility specific infection preventionists for the period from January 1, 2014 to 
September 30, 2014. Post-intervention VAE data were collected on a monthly basis by facility 
specific infection preventionists from November 1, 2014 until February 28, 2015. Descriptive 
statistics were used to assess and compare facility specific, as well as cumulative pooled mean 
data for all four sites. Comparisons of pre- and post-intervention VAE counts, VAE rates, patient 
ventilator days, and changes in VAE incidence rates were discussed in Chapter 4 (Table 4.4).  
As shown in Table 4.5, the pooled mean VAE incidence rate for the four facilities 
declined by 1.8 cases per 100 ventilator-days in the post-implementation phase. However, this 
drop was not statistically significant, Χ2 (1, N = 4,846) = .37, p = .54. Although most facilities 
experienced decreased VAE rates, facility A experienced an increase in VAE rate of 4.5, which 
was also not statistically significant, Χ2 (1, N = 951) = .22, p = .64. The study anticipated that low 
staff engagement, as evidenced by lower documentation compliance would correspond to 
higher VAE rates. Therefore, additional statistical analysis was performed by utilizing 
Spearman’s rank correlation coefficient to determine if staff compliance with documentation of 
the EBP intervention would be correlated with decreased VAE rates. Ultimately, the increased 
VAE rate at Facility A proved unrelated to documentation compliance. Although the study did 
not track staffing metrics, the author’s impression is that increased nurse turnover and use of 
contingent labor at Facility A may have contributed to its outlier result. Whereas data does not 
exist to draw firm conclusions about this outlier, evidence does exist to draw conclusions about 
the lack of statistical significance of the results.  
Post-implementation VAE rate changes may have been found not to be statistically 
significant due to a variety of factors. First, there was a relatively small difference between the 
pre-intervention and post-intervention VAE rates at the study sites. The VAE incidence rates at 
most participating facilities were low to begin with and declined by 1.8 post-implementation. The 
low rates decrease the detectability of changes. However, the findings are consistent with the 
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published evidence (Dudeck et al., 2013a; 2013b; 2013c; Klompas et al., 2014; Klompas, 
Kleinman, & Murphy, 2014; Lilly et al., 2014). Published evidence suggests that VAE incidence 
rates have decreased as compared to previous VAP rates due to the specificity of the new 
surveillance definition as proposed by the NHSN in 2013. Second, seasonal variability in the 
VAE rates may have existed at all the participating sites. Seasonal staffing issues and seasonal 
changes in the incidence of disease processes that contribute to the exacerbation of co-morbid 
conditions may have contributed to the temporal variability. According to Lilly et al., (2014), the 
new VAE surveillance definitions are less sensitive, are more resistant to manipulation, and do 
not adequately account for temporality.  Lastly, the aggregated data utilized in this study was 
relatively small (n=4), when compared to larger, more comprehensive studies that include high-
risk patient populations in academic medical centers and trauma centers.  Larger, more robust 
multi-facility studies that include teaching and specialty critical care units tend to have more 
variability in VAE incidence rate changes (Dudeck et al., 2015; Herndon, 2012). Dudeck and 
colleagues conducted a study in coordination with the NHSN that included critically ill patients 
from over 3,000 hospitals of varying sizes that actively participate in the NHSN’s HAI 
surveillance program. Critical care units, at larger teaching institutions, that care for high risk 
patients with severely compromised bronchial-pulmonary air exchange, such as trauma and 
burn critical care units, experience both an increased incidence and statistically significant 
change in VAE rates (including VAP) when compared to the smaller critical care units, such as 
the four enrolled in this study (Dudeck et al., 2015; Klompas et al., 2014; & Klompas et al., 
2015).  
Compliance and Adherence to EBP intervention.  
Compliance with the EBP intervention was tracked at all four facilities individually and 
cumulatively (Table 4.2). Facility B had a 70% compliance rate and had the lowest pre-
intervention VAE incidence rate among the four facilities (6.9 per 1000 ventilator days), 
suggesting that nurses at facility B were already effective at preventing VAE before the project. 
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On the other hand, facility A appeared to have the greatest challenge with VAE rates in the pre-
implementation period and was the only site to experience an increase in VAE rate in the post-
implementation period. Possible contributing factors included high patient census, benefit and 
staffing changes which may have impacted employee satisfaction leading to high turnover and 
use of contingent staffing. Although the study did not include collection of staffing metrics, the 
quality of care delivered to critically ill patients is understood to be sensitive to experience of the 
nursing staff. At facility A, the investigator perceived a greater presence of contingent nurses 
and nurses with limited critical care experience. However, these factors do not, on their own, 
fully account for the lack of statistical significance in the results. 
Whereas, facilities B, C, and D experienced decreases in VAE rates, the level of 
analysis selected may have played the greatest role in hindering a finding of statistical 
significance. Since results were aggregated for each facility over two periods, it was not 
possible to control for patient specific risks or stratify data to reveal hidden trends. Future 
research may benefit from performing analysis at the individual patient level with access to the 
full range of data elements in the electronic medical record.  
Furthermore, the use of aggregate data analysis effectively reduced the study’s sample 
size from thousands of ventilator days to four sites. That small sample size reduced the ability of 
the analysis to find statistical significance in the results. Nonetheless, various statistical 
techniques were employed in the effort to draw meaningful conclusions from the study’s results. 
Statistical analysis was performed using Spearman's ρ in order to determine if 
compliance with the intervention’s documentation was correlated with a change in VAE rate. 
Spearman's ρ was applied to two variables: facility compliance with documentation of the 
evidence based intervention, and; changes in VAE rate following the intervention (Table 4.5).  
Based on the results of the study, there was a moderate direct correlation between intervention 
documentation compliance and differences in VAE rates, r (4)= .4, p< .05, but this correlation 
was not statistically significant (p = .5). Therefore, these findings provide preliminary evidence of 
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a trend towards reduced VAE rates using a staff education program to promote evidence-based 
oral assessments for mechanically ventilated patients residing in intensive care units.   
Applicability of the Theoretical Framework 
 Rogers’ Diffusion of Innovation (DOI) was selected as the guiding theoretical framework 
for this EBP project. This well-established change model has been used in over 5,000 research 
studies since it was first introduced in 1962 (Rogers, 2003), and it proved to be similarly useful 
for this EBP project as well.  
Fit of the EBP framework  
Rogers’ Innovation Process in Organizations (2003, p. 421) consists of five stages within 
two broader categories known as the initiation and implementation phases. The initiation phase 
consists of the agenda-setting and matching stages where information gathering, 
conceptualization, and pre planning occurs in order to define the organization’s problem and 
facilitate the perceived need for an innovation or solution. During the initiation phase, the 
principal investigator identified a clinical practice problem and assessed internal and external 
factors in order to develop a solution to best fit the organization’s agenda. Issues of importance 
to the organization such as priority, intended purpose and outcomes were ascertained from key 
stakeholders. The PICOT format was utilized to initiate a literature search for all relevant 
evidence. The search affirmed the need for incorporating standard oral assessments as part of 
an evidence-based oral hygiene protocol for patients on mechanical ventilation to prevent VAEs 
within the organization. Although current evidence outlined oral assessment mitigation 
strategies to reduce or eliminate VAE, the organization had not been following those 
recommendations.  
The implementation phase consists of the redefining/ restructuring, clarifying and 
routinizing stages. These three stages consist of all events, actions, and decisions involved in 
getting an innovation adopted. Initially, during the redefining/ restructuring stage, the innovation 
is incorporated into the organization. As implementation begins to occur, stakeholders become 
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more comfortable with the new initiative and accommodation begins to occur as changes are 
required and as barriers are identified. Adjustment may occur with both the organization and the 
innovation. However, there is a narrow window of opportunity to make appropriate 
modifications; thereafter, the innovation will be rapidly routinized and embedded within the 
organization (Rogers, 2003, p. 424). 
During the clarifying stage, the innovation becomes widespread across the entire 
organization. Implementation processes should be monitored to ensure continued support and 
stakeholder buy-in. In the case of this EBP project, changes had to be made to accommodate 
the organizational agenda, stakeholder needs, and environmental functionality. Social 
reconstruction often results during this stage. During this EBP project, key stakeholders had to 
be reassured that the principle investigator would continue to monitor progress and clarify staff 
concerns. 
The routinizing stage occurs when the innovation becomes ingrained within the 
organization’s regular activities. The successful adoption of an innovation signifies the end of 
the innovation process. Sustainability of an innovation, also known as “institutionalization”, is 
dependent on perceived need and on stakeholder participation in creating and implementing the 
innovation (Goodman & Steckler, 1989; Rogers, 2003). Incremental change results, most often, 
when innovation adoption occurs as a result of an authoritative decision. However, 
transformational change occurs when collective innovation-decisions are made, due to wider 
participation (Rogers, 2003, pg. 429). 
Applying the theoretical framework. Rogers’ DOI framework is applicable to this EBP 
project as it elucidates how adopters perceive new characteristics of a practice change or 
innovation. Rogers’ (2003) framework guided the principle investigator in communicating and 
prioritizing the innovation. The innovation for this EBP project was the implementation of a 
standardized oral care assessment guideline in the critical care setting at four facilities. During 
the knowledge stage of this EBP project, the principle investigator met with and spoke to facility 
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stakeholders, unit leaders, and key opinion leaders within each unit at the participating facilities. 
Key leaders included the regional director, department managers, and influential stakeholders 
(i.e. clinical nurse specialists, IRB director, infection preventionists). Gaining early acceptance 
and support from opinion leaders was crucial to the success of this study. Once formal approval 
was garnered, the project leader was then able to embark upon communicating the innovation 
within the organization’s social system.  
The diffusion process was transmitted to critical care and intermediate care nursing staff 
through the use of educational programs offered during the day and evening hours in order to 
accommodate both the day and night shift staff. The educational presentation was also 
uploaded onto YouTube and communicated to staff member via posters. Educational posters 
and notebooks were strategically placed in all participating units. The educational programs 
allowed for an open dialogue between the principle investigator and the nursing staff. 
Interchanges of ideas, thoughts, and opinions were verbalized. Nonverbal forms of 
communication were noted allowing both the investigator and staff to probe for a deeper 
understanding of the problem, incidence of VAE, and the critical care unit culture. The 
investigator controlled staff uncertainty by listening, educating, brainstorming, and sharing ideas 
at each encounter. Ultimately, successful adoption of an innovation is reliant on how potential 
adopters perceive the innovation (Rogers, 2003).   
The DOI framework places adopters into five categories depending on how readily they 
accept and incorporate innovative change initiatives. During the first two weeks of 
implementation, the principle investigator attended morning and evening staff meetings to 
explain the purpose of the EBP project and to underline the importance of the intervention to 
patient outcomes. Targeting innovators and early adopters during the early stages of a change 
effort is crucial to triggering the critical mass necessary to catalyze a change (Rogers, 2003).  
Initiation of the innovation process was accomplished by familiarizing adopters with the 
knowledge necessary to understand the purpose and function of the innovation. 
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The innovative diffusion curve depicts late majority and laggards at the opposite end of 
the spectrum from early adopters. Late majority individual are skeptical about innovation and 
require peer pressure prior to initiating a change. Typically, late majority individuals adopt the 
innovation after the majority of the adopters incorporate the practice change (Rogers, 2003). 
Laggards are often deeply traditional, cautious, and suspicious of change according to Rogers 
(2003). During the EBP implementation period, the investigator targeted educational resources, 
through exchange of ideas, at these two groups comprised of highly experienced registered 
nurses with longevity at their respective facilities.  
During the persuasion stage, potential adopters must develop a positive outlook and 
should view the innovation as beneficial. Five influential factors that are crucial to the successful 
acceptance of an innovative process change include: relative advantage, compatibility, 
complexity, trialability, and observability. Rogers (2003) contended that these characteristics 
positively correlated with the rate of innovation adoption. 
Relative advantage. Rogers’ DOI framework facilitates the adoption of the innovation by 
conveying the relative advantage of the innovation (Rogers, 2003, p. 225). The framework 
accounts for the healthcare setting as the unit of adoption and it facilitates the adoption of the 
innovation by conveying potential benefits as improved outcomes relevant to the setting and 
project goals (Rogers, 2003, p. 225). Past investigations have reported a positive relationship 
between relative advantage and the rate of adoption (Rogers, 2003).  As a result, the principal 
investigator rounded at the four facilities on a biweekly bases and monitored documentation as 
an indicator of project compliance to ensure the project’s momentum. The principal investigator 
continued to educate, motivate, and remind staff that the EBP project was being implemented.  
Phone calls were made to the day and night shift charge nurses, at all participating facilities, on 
a twice weekly schedule. 
 In late November 2014, all four facilities implemented new pulmonary and ventilator 
documentation profiles in the electronic medical record. All four facilities were implementing a 
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pneumonia prevention initiative that paralleled this EBP project. As a result, when that initiative 
began, staff was initially unsure if they had to continue documenting their oral health 
assessments as outlined in this study. This required the EBP principal investigator to re-inform 
facility staff members to continue with the implementation process.   
Compatibility. Innovations must be compatible with the values, past experiences, and 
needs of the adopter (Rogers, 2003). The innovation was compatible with the organization’s 
mission to provide safe, cost effective, quality healthcare to promote good healthcare outcomes. 
This EBP project was consistent with the organization’s goals, needs and workflow. Adopters 
were comfortable with the innovation since it incorporated existing indigenous knowledge 
systems. As a result this was not regarded as unnecessary or foreign. The staff nurses 
perceived the innovation to be consistent with current practice and beneficial to the patients in 
the form of improved oral health, infection control, and quality healthcare outcomes. Critical care 
unit leadership was supportive of this project as it addressed current goals to reduce VAE rates 
and variability. Therefore, this EBP project aligned well with the organization’s stewardship 
initiative to reduce hospital acquired infections, particularly pneumonia, regionally. 
Complexity. Complexity is described as “the degree to which an innovation is perceived 
as relatively difficult to understand and use” (Rogers, 2003, p. 15). Innovations are easier to 
adopt when they do not pose barriers to existing workflow processes (AHRQ, 2008, p. 2-222).  
Registered nurses found the EBP intervention, as outlined by the BOAS and MPS, to be 
intuitive and practical to their practice. Documentation, at all participating sites, was done via 
electronic medical record. Consequently, the end-users (i.e. registered nurses), reported the 
projects paper documentation method to be inconsistent with their workflow. The EBP 
investigator alleviated concerns by consulting with end-users, project champions, and clinical 
leadership regarding workflow optimization for this project. Staff nurses, project champions, 
charge nurses, clinical nurse specialists and unit managers were instrumental in advising the 
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EBP investigator regarding their workflow practices in order to reduce complexity and facilitate 
adoption. 
Complexity encompasses organizational barriers to change. One month post-
implementation, a consulting group working at the corporate level of the organization, 
implemented three quality improvement initiatives. One focused on VAP reduction. Since the 
measures were synergistic with the EBP project, their workflow aligned well with the existing 
documentation infrastructure. However, staff reported difficulty understanding project 
distinctions and documentation requirements. Professional communication and team 
collaboration presented synergistic opportunities for enhanced patient safety (AHRQ, 2008). 
The principle investigator alleviated participant concerns through frequent communication.  
Trialability. According to Rogers (2003), “trialability”, is the degree to which an innovation 
may be experimented with on a limited basis” (p. 16). Trialability positively correlated with the 
rate of adoption, especially among early adopters. As part of the implementation methodology, 
the principle investigator allowed nursing staff to use and familiarize themselves with the BOAS 
and MPS oral assessment tools. The tools were distributed to nursing staff on colored stationary 
in an easy to read font. Documentation forms were also distributed and staff was encouraged to 
practice documenting and familiarize themselves with the format prior to implementation. The 
principle investigator noted that the site with the highest documentation compliance 
institutionalized the Oral Health Assessment as part of everyday practice.  
Observability. The last characteristic in DOI framework is observability. Rogers (2003) 
defines observability as “the degree to which the results of an innovation are visible to others” 
(p. 16). Role modeling and peer-to peer observation are two examples of how adopters can 
motivate each other to adopt new innovations. This EBP intervention yielded observable results 
immediately upon completion. Staff visualized the decrease in oral plaque within the patients’ 
oral cavity. Despite, the objective evidence in oral plaque removal, staff did not consistently 
document the provision of oral care. However, VAE changes, unlike physical plaque removal, 
PREVENTING VAE 83 
are not readily apparent to staff. The results of this study suggest that compliance with timely 
oral care, when coupled with oral care assessments, may correlate with a decrease in VAE 
incidence rates.  
Decision, implementation, and confirmation make up the final three stages of Rogers 
Innovation-Decision Process. During the decision stage, potential adopters determine either to 
adopt or reject the implementation of a proposed innovation.  As previously stated, this EBP 
project was implemented at four intensive care units at four healthcare facilities that are owned 
and operated by a larger health care organization. The decision to implement facility changes, 
at the participating study sites, was at the discretion of two key organizational leaders. The two 
leaders stated an interest in addressing a pressing issue, that being increases in VAE rates.  As 
a result, the principal investigator for this EBP project, gained support from organizational 
stakeholders. Formal meetings were conducted with individuals in the following roles: (a) 
regional director for critical care and infection control services at all four participating facilities; 
(b) nursing unit managers, responsible for daily unit management; (c) clinical nurse specialists, 
responsible for nursing education and unit support services; and (d) infection preventionists, 
responsible for infection control and monitoring of infection related quality measures at specific 
sites. IRB approval, to implement the EBP project, was granted after garnering support from key 
opinion leaders.   
The implementation stage initiates the innovation diffusion process within the clinical 
environment. This was accomplished by developing a standardized oral care guideline that 
incorporated existing oral care protocols, oral care procedures, and a standardized oral care 
assessment tool. In essence, facility specific oral care practices and VAP bundle use were 
incorporated into the innovation. Secondly, the provision for staff education concerning evidence 
based oral care practices, oral care assessment, and the role of oral biofilm in the development 
of VAEs, was discussed from an epidemiological perspective. The education program was 
delivered to intensive care and intermediate care nursing staff on the day, evening, and night 
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shifts. Presentation and related educational materials were made available in a variety of 
formats to maximize the spread of the innovation. The presentation was delivered orally, via 
PowerPoint presentation, and via abbreviated YouTube address and QR code displayed on a 
poster. A project binder that included the purpose of the study, project outline, standardized oral 
care guideline, BOAS and MPS tools, PowerPoint slides, and references, was delivered to each 
participating intensive care unit.  
Prior to implementation, discussions with opinion leaders revealed that there was VAE 
variability across participating facilities. Support from unit leaders was eventually obtained. This 
support was necessary to ensure project compliance within individual critical care units. 
Innovation diffusion within an organization requires change management to facilitate and 
encourage people to adopt initiatives. Corporate opinion leaders ensured that unit leaders were 
implementing the oral care guideline at the study sites and documenting oral care practices on 
the Oral Health Assessment Tool (Figure 4.2). Despite the additional oversight, documentation 
compliance did not increase. This may be due to the implementation of a parallel VAP quality 
improvement project by a consulting firm working with the organization. The consulting firm 
integrated documentation changes within the EMR; thus, increasing adoption and 
documentation compliance for their initiative. Workflow optimization was critical to encouraging 
and sustaining innovation adoption within the clinical setting.  
Strengths and weaknesses of the theoretical framework. Rogers’ Diffusion of 
Innovations framework was adequate in guiding this EBP project. The DOI framework provides 
effective strategies for implementing change and guiding the organizational adoption process. 
Rogers’ framework assisted the principle investigator to identify influential leaders that would 
facilitate access and acceptance of the practice change. For example, it was important to attain 
support from key opinion leaders prior to initiating the implementation process. Influential 
leaders within a hierarchical organization wield influence over subordinates; their support was 
necessary for the success of this EBP project.  
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A second strength of the DOI framework was identifying and understanding existing 
workflow processes in place at each participating facility. Understanding and incorporating 
workflow at each specific study site was essential to system participation and practice adoption. 
Only then would participants appreciate the relative advantage of the new practice, as 
supported by the literature, relative to standard practice. The evidence based practice change 
was developed to be easy to understand, incorporating participants’ foundational knowledge to 
streamline documentation efforts. The innovation was compatible with existing organizational 
mission and values of providing an environment where innovation, technology, compassion and 
knowledge converge to provide safe, quality healthcare services to all patients. Lastly, the 
change was observable. Staff and patient family members provided positive feedback regarding 
their perceptions of changes in the patient’s oral health status.  
There were several limitations to using Rogers’ framework. While opinion leaders 
encouraged and motivated staff members to utilize the change initiative, it was difficult to 
determine whether individuals were actively embracing the change. The DOI framework does 
not provide an adequately process for engaging late adopters and laggards. Continued 
education, staff engagement and clinical support will encourage staff to learn about the inherent 
benefit of maintaining this EBP initiative. Therefore, the principal investigator will reinforce 
engagement by providing staff and the IRB with this EBP study’s results. 
A limitation of Rogers’ Innovation-Decision Process is that it depicts a linear pathway.  
However, the principal investigator iterated between the different stages throughout the study. In 
particular, the stages of persuasion, implementation, and confirmation required iteration. For 
example, the principal investigator continued to attend staff meetings, routinely rounded at all 
study sites, and continued to provide educational reminders, educational in-services and 
provided support for all staff nurses including new hires and temporary staff.  
Applicability of the EBP framework 
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Rogers’ Diffusion of Innovations-Decision Process (2003) guided the design and 
implementation of this EBP project. The framework’s Innovation-Decision Process consists of 
five phases that are designed to guide integration of research into practice. 
 
Figure 5.1 
Diffusion of Innovation Stages  
 
 
 
 
Strengths and weakness of the EBP framework. Rogers’ Innovation Process (2003) 
was a good fit for this EBP project, as it was rigorous enough to ensure the successful 
implementation of the project. The EBP framework provided a five-stage guide that resulted in 
the design and implementation of an EBP initiative. The principle investigator developed a 
PICOT question, appraised the relevant literature, developed a practice guideline and 
developed a nursing staff education program. Another strength of the EBP framework was that it 
facilitated adaptive changes during the redefining and clarifying stages of the process. Rogers’ 
Innovation Process was the cornerstone of the entire project.  
Limitations.  A weakness of Rogers’ Innovation Process is that it does not adequately 
address pro-innovation bias (Rogers, 2003). Such bias was evident at Facility B, where the 
sense of urgency to adopt this change effort was pre-existing. This site was the first to commit 
to the study, had the lowest pre-implementation VAE rate and extremely high documentation 
compliance. In order to mitigate pro-innovation bias, the investigator invited participating 
stakeholders to develop, critique, and provide feedback regarding the proposed innovation. 
Another limitation is individual stakeholder blame bias for non-adoption. However, the 
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investigator continued to support, educate, and reinforce the purpose of the change initiative in 
an effort to mitigate potential limiting factors by individual stakeholders.  
Rogers’ Innovation Process does not allow for the adequate evaluation of the innovation. 
While the innovation’s process provides a mechanism for disseminating an innovation, it lacks 
systematic criteria by which to evaluate contextual outcomes for the purpose of comparison. 
Essentially, the innovation process fails to appraise the circumstances related to adoption or 
non-adoption, as well as the consequences and rationales associated with incomplete or failed 
adoptions (Meyer, 2004). However, it does provide some benchmarks for innovation diffusion 
within a larger system.  
Strengths and Limitations of the EBP project 
 Strengths. The study succeeded in several respects. First, the research and data 
collected support the use of an evidence based oral health assessment during the provision of 
oral care. Although results were not statistically significant, there is preliminary evidence that 
adherence to oral care guidelines decreased VAE counts (including VAP). A second area of 
strength was the use of the APN skill set. The APN provides value to the organization by 
effectively using diverse skill sets to improve patient outcomes and healthcare quality, minimize 
costs, and increase patient safety. This additional data contributes to the current evidence by 
adding new knowledge regarding the utility of APN-led infection control practice changes (Goss 
& Bryant, 2014). Lastly, the implementation of the innovative change benefited nursing staff and 
the organization. The nursing staff in the critical care units expressed satisfaction with the 
educational program as it enabled them to be more cognizant, not only of oral care practices, 
but also, of the existence of microorganisms within the clinical environment. The staff’s 
increased awareness empowered them to adopt the innovation and change their practices, thus 
contributing to lower VAE rates.   
This EBP project demonstrated that advanced practice nurses are in an ideal position to 
coordinate evidence-based system-level interventions to reduce VAE. Furthermore, registered 
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nurses and patients’ family members expressed satisfaction with this project. Nurse led 
interventions are more likely to overcome adoption challenges due to nurses’ familiarity with the 
organization’s culture, environment, clinical expertise, and access to key stakeholders.  
Limitations. This EBP project utilized aggregate data from four distinct facilities with 
different workflow processes and levels of staff engagement. Aggregated data is the 
consolidation of data relating to multiple patients. This data is not patient specific, and therefore 
cannot be traced back to a specific patient. The results of this study cannot be generalized at 
the patient level. Aggregate data results are primarily utilized by organizations for process 
improvement as quality indicators and for strategic planning.  
Workflow processes at the multiple study sites impacted this study. Therefore, results 
and compliance differed significantly. This, coupled with aggregated statistics and a sample size 
of four facilities (n=4), was likely to have contributed to non-statistically significant findings 
despite improved VAE frequencies.  
Lastly, it was difficult to assess and maintain staff engagement given that all four 
participating sites experienced varied confounding factors that affected their compliance and the 
efficacy of this study. In order to maintain the engagement of some participants, it was 
necessary to elicit repeated reaffirmations of support from senior leaders. Furthermore, other 
initiatives within the organization had the potential to introduce confusion regarding study 
methods. This was apparent when staff notified the principal investigator that the standardized 
oral health assessment form had been uploaded into the EMR. Subsequent inquiry revealed 
that the organization had made revisions to its VAP prevention documentation in the electronic 
medical record. These revisions were unrelated to this study and utilized different data 
elements. In future rounding sessions, the need to continue use of the Oral Health Assessment 
Tool was reinforced. However, since the Oral Health Assessment Tool was not mandatory, 
compliance rates dropped at a site that had not yet institutionalized the change. Due to nurses’ 
use of their organization’s patient specific documentation method, that data was not available 
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for analysis. Only results documented on the paper based standardized oral assessment form 
were included in this study. This may have limited the power of the assessment tool to detect 
compliance with the overall intervention. 
Implications for the Future 
 Practice. Evidence based practice changes integrate research and clinical expertise 
with the primary goal of improving patient and healthcare outcomes. The advanced practice 
nurses’ multifaceted skill set and clinical expertise lay the foundation for an increased role within 
healthcare organizations. As clinical educators, consultants and providers, APNs can use their 
strong leadership abilities to enable transformational change. APNs are in a prime position to 
promote and implement EBP recommendation into clinical practice and can play a pivotal role in 
the adoption and uptake of new innovative practices. Future research may involve developing a 
systems level approach to increase oral care documentation rates. Given ongoing and 
impending national healthcare reforms, advanced practice nurses could help healthcare 
organizations adapt by developing and guiding change management initiatives.  
Theory. The epidemiologic triangle and Rogers’ DOI Framework and Innovation 
Process were useful in guiding the development and implementation of this EBP project. 
However, Rogers’ Innovation Process was of limited utility when evaluating the project 
outcomes. Future theory development should explore why the translation of research to practice 
is lagging, especially in the area of VAE prevention, and develop strategies to improve 
compliance with EBP recommendations. Additionally, future theory development needs to 
address needs from the family’s perspective. Theory that integrates the family unit provides 
context to the problem and may even serve to encourage practice change and adoption.  
Research. A review of the literature revealed thousands of research articles describing 
the implications of VAE development. However, relatively few articles evaluated barriers to 
implementation such as standards and procedures related to the provision of oral care and VAE 
prevention, staff compliance, and staff feedback regarding change initiatives. Research that 
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focuses on increasing individual, group, and system adoption of innovation needs to be 
undertaken. Future research should focus on developing strategies for the successful adoption 
of and compliance with, the provision of evidence based oral care and oral health assessment 
documentation. Additionally, future research could incorporate patient level data as well as the 
patient’s or family’s perspective. In so doing, researchers could access the richer context that 
may provide greater depth and understanding of change initiatives and their adoption within the 
critical care setting.  
Education. After an innovation is adopted, practice changes are affirmed and become 
routinized into everyday practice. VAE prevention requires commitment and continued staff 
education at all levels.  Therefore a multidisciplinary approach and transparency should be 
encouraged within organizations. Educating new personnel during orientation and providing 
yearly skills training is imperative to sustaining a long lasting practice change. Additionally, an 
intra-organizational team based approach should be used to foster organizational cohesiveness. 
Multidisciplinary approaches can alleviate facility specific barriers that interfere with the adoption 
of current EBP guidelines. 
Conclusion 
This EBP project provided useful information for critical care nurses, advanced practice 
nurses, nursing managers, and other healthcare providers regarding the strength of the 
evidence published in the literature. Based on the evidence presented, practice guidelines can 
be utilized to implement meaningful change within the ICU setting. The effects of oral hygiene 
care on the incidence of hospital-acquired infections, including VAE, among critically ill patients 
are important. Timely oral assessments, mechanical brushing, use of CHG solutions, 
maintaining appropriate infection control measure during the provision of care, and staff 
educations, will reduce the incidence of ventilator associated conditions (Koemam et al., 2006; 
ICSI, 2011; Shi et al., 2013). 
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Although statistical significance was not found, this study provided preliminary evidence 
that routine oral assessment and timely intervention in mechanically ventilated patients are 
useful components of comprehensive oral care practices to prevent or reduce the incidence of 
VAE. 
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